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ABSTRACT
The purpose of this study was to investigate the mechanism of action
of lipolysis by growth hormone in rat adipocytes. GH-induced lipolysis, in
contrast to that of isoproterenol (ISO), is slow in onset (lag time lh), small in
magnitude (--2X basal) and requires corticosteroid. Evidence for direct
coupling between GH receptors and adenylyl cyclase or G-proteins is lacking,
and although we could detect no measurable change in cAMP content after
treatment with GH + dexamethasone (Dex), it is likely that cAMP activation
of protein kinase A is a central event in GH-induced lipolysis. Rp-cAMPS, a
competitive antagonist of cAMP was equally effective in decreasing lipolysis
in tissues treated with GH/Dex or a comparably lipolytic dose of ISO.
Incorporation of 32p from y-32P-ATP into kemptide, a synthetic oligopeptide
substrate for protein kinase A, was increased in homogenates of GH/Dex-
treated tissue. This increase was correlated with increased lipolysis. Earlier
estimates based upon 32P-ribosylation of Gi catalysed by pertussis toxin (PTx)
suggested that the abundance of Gi in adipocyte membranes was decreased 4h
after treatment of hypophysectomized rats with GH. We therefore examined
the possibility that changes in amount or distribution of G-proteins in
adipocyte membranes might account for the lipolytic action of GH.
Homogenates of GH/Dex-treated and control adipocytes were subjected to
differential centrifugation and the abundance of G-proteins in low speed, l6k
x g (16k), pellets and high speed, lOOk x g (lOOk), pellets were determined by
quantitative Western analysis with densitometry. A 35% loss of Gia2 from
the l6k pellet compared from tissues treated with GH/Dex was associated
with a 70% increase of Gia2 in the lOOk pellet. No change in Gsa was
observed in the l6k pellet but a 35% loss of Gsa was seen in the lOOk pellet.
The G proteins in the l6k pellet were fractionated on a continuous sucrose
gradient followed by quantitation with Western analysis or autoradiography
after 32P-NAD ribosylation. Gia2 was consistently shifted from heavier 
lighter fractions of the l6k pellet after treatment with GH/Dex. Similar shifts
of Gsa were not seen. The distribution of 32P-Iabelled proteins was
comparably altered after incubation of homogenates of control and GH/Dex
treated adipocytes with PTx and NAD. These shifts were blocked by
treatment of adipocytes with 100JlM colchicine which also blocked the
lipolytic action of GH/Dex. We propose that an action of GH/Dex on the
cytoskeleton of fat cells may change the cellular distribution of G-proteins in a
manner that produces a relative decrease in the tonic inhibitory influence of
Gi on adenylyl cyclase.
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Inoduction and--ackground
Growth hormone (GH) was discovered and named for its growth
promoting effects (Evans and Long, 1921; Knobil and Greep, 1959). If
promoting growth were its only action, one would expect GH concentrations
in blood to be greatest during childhood and adolescence and low 
negligible in the non-growing adult. However, levels of GH remain high
(--
60% of that in adolescence) up until the 3rd decade of life when they drop
to about 25% of the levels observed in adolescence (Zadik et aZ. 1985). In the
non-growing individual, it is likely that GH's primary role may be as a
regulator of metabolism. role for GH in fat metabolism was first
recognized in 1934 when Lee and Schaffer (1934) found that chronic
treatment of rats with pituitary extracts rich in growth promoting activity
increased lean body mass at the expense of body fat. Subsequent confirmation
of decreased body fat after treatment with purified GH and findings of
decreased respiratory quotient, increased ketogenesis, and accumulation 
hepatic fat supported the notion that GH increases fat mobilzation and
oxidation (Goodman and Schwartz, 1974). Experiments with rats on limited
food intake suggested that continued growth in response to GH was possible
only as long as there was sufficient mobilzable fat to fuel the growth process
(Greenbaum, 1953) and linked fat mobilzation to growth stimulation. After
"'.,",,-,'!;. :... .
it was discovered that free fatty acids (FFA) in blood are the form in which fat
is mobilzed from adipose storage depots (Dole, 1956; Gordon and Cherkes,
1956), Raben and Hollenberg (1959) and Goodman & Knobil (1959) reported
increases in FFA concentration in blood following injection of GH to non-
growing humans or monkeys. Development of radioimmunoassay for GH
led to the observation that GH levels fluctuate according to metabolic
demands such as increased GH secretion during fasting (Glick et al.,1965).
This evidence supports the notion that GH may act as a regulator of
metabolism as well as of growth.
The metabolic effects of GH compliment its growth promoting
effects in that GH tends to influence metabolism in ways that directly or
indirectly enhance or defend the lean body mass. Thus GH directs the flow of
metabolic substrates towards consumption of fat and away from the
breakdown of proteins.
Some of the growth promoting effects of GH (for example, bone) are
achieved through the insulin-like growth factor I (IGF-I), which is produced
by liver and peripheral cells in response to GH. Insulin-like growth factor
stimulates mitosis and/or differentiation of fibroblasts, prechondrocytes, and
other progenitor cells (Isaksson et aZ. 1987). Upon stimulation by GH
prechondrocytes release IGF-I which operates in an autocrine fashion
(Isaksson et al. 1987) to stimulate clonal expansion and differentiation. In
contrast, the metabolic effects of GH are thought to be achieved through a
direct action, without an intermediary such as IGF- , on cells in adipose
tissue, liver, muscle, and pancreas. The metabolic effects of GH may be
divided into two types: acute and chronic effects. The acute effects are rapid
in onset (within minutes) and short lived. Acute effects are seen in cells that
have been deprived of GH for at least 3 hours and are sometimes referred to
as insulin-like effects because they resemble many of the actions of insulin
(Goodman, 1965). For example, increased glucose uptake and oxidation to
C02. Chronic effects are seen in the time frame of hours or days and are
contrary to the effects of insulin; that is, glucose metabolism by muscle and
fat are reduced and fat metabolism is accelerated (Goodman, 1968).
When physiological amounts of GH are administered to GH-
deficient or normal experimental animals or human patients, characteristic
changes are observed depending on duration of treatment and the prevailng
physiological state. In non-growing subjects, GH maintains body
carbohydrate reserves during starvation and thereby, perhaps prolongs
survival. In the growing subject, nitrogen is retained in structural proteins
and in enzymes involved in increasing lean body mass (Kostyo and Nutting,
1974). As muscle and liver mass increase, so too do nucleic acids and
carbohydrate reserves (Altszuler, 1974). Al though body fat increases
somewhat during GH-stimulation of growth in well nourished young
subjects, the general metabolic trend is towards increasing the ratio of lean
body mass to body fat. Therefore, in GH treated subjects, there is an increase
in the number of fat cells but paradoxically, the total mass of stored
triglyceride decreases relative to other body constituents (Morikawa et al.,
1982; Nixon and Green, 1984). In non-growing human adults, GH decreases
body fat through the combined actions of decreasing fat synthesis and
increasing fat mobilzation (Sa 10m an et al. 1989; Rudman et aI. 1990).
Repeated injections of supra-physiological doses of GH have been
reported to increase circulating glucose and insulin concentrations in
humans (Davidson, 1987), dogs (Altszuler, 1974), and pigs (Gopinath and
Etherton, 1989), as well as blood levels of FFA and glycerol. Increased insulin
levels may contribute to decreased glucose tolerance seen in these subjects
since high levels of insulin decrease the abundance of insulin receptors in
target cells (down-regulation) (Davidson, 1987). In dogs, the pancreatic beta
cells may be irreversibly damaged by chronic treatment with high
concentrations of GH, perhaps as a result of prolonged hypersecretion of
insulin due to increased circulating levels of glucose. (Pierluissi and
Campbell, 1980).
Control of lipolysis
A wide variety of hormones has been shown to stimulate lipolysis
in rat adipose tissue in vitro. The earliest investigations demonstrated
sensitivity to catecholamine (Gordon and Cherkes, 1956; White and Engel
1958a), glucagon (Steinberg et al. 1959), ACTH, and GH (White and Engel
1958b; Raben and Hollenberg, 1959a), and various pituitary hormones
(Steinberg and Vaughan, 1965; Robison et ai., 1971). These results were
obtained originally with adipose tissue segments, but similar effects are also
evident in isolated fat cells.
Although many hormones appear to be lipolytic in vitro few can be
regarded as physiologically important regulators of lipolysis. The fact that
catecholamines elicit lipolysis in many mammalian species suggests that they
may be the principle lipolytic agents in mammals (Scow and Chernick, 1970).
However, the concentrations effective in vitro (1-100 Jlg/L or 5. 550 nM) are
very high (perhaps to compensate for the rapid oxidation of catecholamine 
vitro) relative ' to those in plasma (0.02- 6 Jlg/L or 0.11-30.6 nM) (Dearborn
and Skillman, 1976). It is possible that such high concentrations may be
attained when noradrenaline is released locally by the sympathetic nervous
system and thus may be more important in regulating lipolysis than
circulating catecholamines of adrenal origin. Stimulation of nerves in
preparations, in vitro, of epididymal fat pads from rat (Correll, 1963) was
shown to cause release of FFAs. Abolishing sympathetic activity 
denervation or with ganglionic blockers was shown to attenuate exercise-
induced lipid mobilzation (Havel, 1968). On the other hand, Wirsen (1965)
and Ballantyne & Raftery (1969) did not find histological evidence for
adrenergic innervation of fat cells in several species, and proposed that
nervous stimulation of lipolysis occurs by release of noradrenaline into the
circulation and alteration of blood flow. Studies for the role of the
sympathetic nervous system in the regulation of lipolysis have been
reviewed by Havel (1968), Brodie et al. (1965), Scow and Chernick (1970) and
Fredholm (1970).
A lipolytic effect of GH was first demonstrated at only very high
concentrations (::1 Jlg/ml) (Jungas and Ball, 1962) but Fain et al. , (1965)
showed that much lower concentrations, as low as 10 ng/ml, were effective
when glucocorticoids were also present. Under these conditions, 1-2 hrs
elapsed before a measurable change in glycerol production was seen. The
stimulation of lipolysis was slow to develop and was prevented by inhibitors
of RNA and protein synthesis. In contrast, the almost immediate lipolytic
effects of ACTH and catecholamine are insensitive to these inhibitors.
In addition to the rapid effects of many lipolytic hormones, there
appear to be long-term endocrine controls of lipolysis. Adipose tissue from
adrenalectomized rats has a diminished capacity to respond to lipolytic
hormones both in vitro and in vivo (Reshef and Shapiro, 1960; Allen and
Beck, 1972), a defect that can be repaired by treatment with glucocorticoids.
Hyperthyroid and hypothyroid animals show increased and decreased
sensitivity to catecholamine both in vitro and in vivo (Debons and Schwartz
1961; Armstrong et al. 1974; Correze et al. 1974). Thyroid hormone has no
direct effect on lipolysis when added in vitro but correction of thyroid status
in the hypothyroid animal also normalizes the sensitivity of adipose tissue to
lipolytic agents (Elks and Manganiello, 1983).
Biochemistry of lipolysis in adipocytes
The cycle of fatty acid esterification to form triglycerides and of
triglyceride breakdown (lipolysis) to release fatty acids and glycerol is an
ongoing process within the adipocyte. Re-esterification of glycerol and free
fatty acids requires the glycerol to be in the form of a-glycerol phosphate.
Free glycerol produced by lipolysis cannot be phosphorylated because
adipocytes are deficient in the enzyme a-glycerokinase (Margolis and
Vaughan, 1962). The only source of a-glycerol phosphate is the triose
phosphate pool which is derived from glucose metabolism. The rate of fatty
acid release thus is sensitive to any factor that affects the rate of glucose
metabolism in adipocytes as well as any factor that accelerates lipolysis. In
addition to promoting lipolysis, GH can inhbit re-esterification by limiting
the availabilty of a-glycerol phosphate by decreasing glucose metabolism
which could theoretically double or triple free fatty acid mobilzation even 
the rate of lipolysis is remaining constant (Goodman, 1968).
Before exploring the lipolytic actions of GH, it may be useful to
review briefly current understanding of the lipolytic process (for detailed
review, see Steinberg and Huttumen, 1972; Steinberg, 1976). Lipids are stored
in adipose tissue in the form of triglycerides which are composed of 3 mol of
long-chain fatty acids in ester linkage with 1 mol of glycerol. Lipolysis is the
step-wise enzymatic cleavage of the ester bonds to release fatty acids and
glycerol. The rate-limiting step seems to be cleavage of the ester bond at the a-
carbon of glycerol and is catalysed by the hormone-sensitive lipase (see
below). Successive cleavage of the remaining ester bonds by the hormone-
sensitive lipase or other tissue esterases progresses rapidly with little or no
accumulation of mono- and diglycerides. Fatty acids that are not esterified
are released into the circulation as FFA. In vitro, only a small fraction of the
fatt acids released from ester linkages escapes from the adipocyte (Goodman
1968; Sinnett-Smith and Woollams, 1989). Also in vitro most fatty acids
within adipocytes, usually more than two-thirds, are re-esterified and hence
trapped within the fat cell as triglyceride. The net rate of FFA mobilzation is
thus determined by the relative rates of the opposing processes of lipolysis
and re-esterification. Although the FFAs released by lipolysis can be recycled
to triglyceride, the glycerol cannot be recycled, since triacylglyceride synthesis
requires a-glycerol phosphate rather than free glycerol, which escapes into
the extracellular space. Therefore the rate of glycerol production, rather than
of FFA production, is a good index of lipolysis (Figure 1).
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The cyclic AMP-mediated lipolytic pathway. Stimulatory (Rs) or inhibitory (Ri)
receptors, through the intennediary actions of stimulatory (Gs) or inhibitory (Gi) G
proteins stimulate or inhibit adenylyl cyclase (AC). Activation of adenylyl cyclase
catalyses the conversion of ATP to cyclic AMP. Cyclic AMP acts as second messenger
to activate protein kinase A , which phosphorylates and activates honnone-sensitive
lipase. Hormone-sensitive lipase catalyses the breakdown of triacylglycerol to free fatty
acids and glycerol. Free fatty acids may recycle to reform triacylglycerol but glycerol
cannot recycle because the formation of triacylglycerol requires a -glycerol phosphate
rather than free glycerol. Adipocytes cannot fonn a-glycerol phosphate from glycerol.
The adipocyte can respond to a wide variety of endocrine and
paracri signals that can either stimulate or inhibit lipolysis. Stimulatory
agents such as adrenaline binds to stimulatory receptors which transduce the
signal and activate adenylyl cyclase via stimulatory guanine nucleotide
binding proteins or G s proteins. Likewise, inhibitory agents such 
adenosine bind to inhibitory receptors which transduce the signal to adenylyl
cyclase via inbitory Gi proteins (Figure 1).
Under resting conditions, adenylyl cyclase in the adipocyte is
suppressed by inhibitory agonists such as adenosine and prostaglandin 
through an autocrine fashion (Kather et al., 1985). These agents presumably
produce a basal level of inhibition on adenylyl cycase which upon removal of
these agents (for example with adenosine deaminase or indomethacin)
relieves inhbition and hence an apparent stimulation of cyclase. Although it
has long been recognized that the a subunit of G has a direct stimulatory
effect on adenylyl cyclase, the abilty of the a subunit of Gi to inhibit adenylyl
cyclase has only been established recently (Taussig et al. 1993; Wong et aI.,
1991).
Lipid mobilizing effects of growth hormone
Growth hormone in vitro has been shown to decrease glucose
metabolism in fat tissues of rodents (Goodman, 1968; Maloff et al. 1980),
humans (Nyberg et al. 1980; Nyberg and Smith, 1977), and other species
including sheep (Sunnett-Smith and W oollams, 1989) and pigs (Magri et al.
1990). This effect was slow in onset, required many hours and was seen both
in the absence (Goodman, 1968; Maloff et aI., 1980; Nyberg et al. 1980; Nyberg
and Smith, 1977; Sunnett-Smith and Woollams, 1989; Magri et al., 1990) and
in the presence of insulin (Walton et al. 1986; Etherton et al. 1987; Cameron
et al. 1987). Reduced glucose metabolism appears to be a direct action of GH
as well as an indirect consequence of diminishing insulin sensitivity.
Reduced glucose metabolism results in decreased de novo synthesis of fatty
acids in the fat cell and decreases the availabilty of a-glycerol phosphate
required for re-esterification. Therefore a higher proportion of newly
liberated fatty acids escape into the circulation as FFA. Growth hormone also
increases lipolysis through a direct action on the lipolytic apparatus and
perhaps also by antagonizing the anti-lipolytic effects of insulin (Rosenbaum
et aI. 1989). All these actions result in decreased body fat and increased FF 
and glycerol in blood.
. "-
Increases in glycerol and FFA production of up to 10 times or
greater, are seen within minutes of incubation of rat fat with catecholamine,
ACTH, or TSH (Vaughan and Steinberg, 1963). Because GH failed to
stimulate lipolysis within this time frame except when high concentrations
of highly purified, but nevertheless impure hormone preparations were used
(Goodman and Schwartz, 1974), the likelihood of a direct lipolytic action was
questioned. The lipolytic effect of GH seldom exceeds twice the basal rate of
lipolysis and has not been observed consistently.
Uncertainty of GH's abilty to increase lipolysis arose in the era in
which GH preparations were obtained from pituitary extracts which were
often contaminated with other pituitary peptides known to be potent lipolytic
agents (ex: ACTH, TSH). Although recombinant GH, derived from bacterial
sources, is free of contamination by mammalian lipolytic hormones
uncertainty of GH's abilty to increase lipolysis persists. Recombinant human
or bovine GH were found to be lipolytic in rat (Goodman, 1984; Elsair et al.
1985) and mouse (Fielder and Talamantes, 1987) adipose tissue, in cultured
mouse 3T3-F422A adipocytes (Dietz and Schwartz, 1991), and in chicken
adipose explants (Campbell et al. 1990; Campbell and Scanes, 1985). Other
investigators, however, found either inconsistent (Frigeri et al., 1982) or no
(Hart et al. 1984) lipolytic action of recombinant bovine GH in rat adipose
tissue.
1v,.
Different findings may result from different experimental
conditions. Hart et al. (1984) obtained negative results in tissues from rats
that had been fasted 48 hours prior to excision of adipose tissue, while the
positive effects reported by Grichting and Goodman (1983) were seen in fed
rats. Frigeri et al. (1982) found small lipolytic effects in tissues of fed, but not
starved rats. In addition, consistent findings of increasing lipolysis
(Goodman, 1984; Grichting and Goodman 1983) reflect the behavior 
adipose tissues only in the 4th hour after addition of GH, when the effect is
fully developed. In contrast, other investigators averaged the rate of glycerol
production over an entire 4 hour incubation period which minimizes any
GH effect by including rates of glycerol production in the 2 hours preceding
the appearance of the lipolytic effect. Furthermore, th s approach compares
glycerol production in response to GH with an inappropriately high control
value since basal glycerol production often declines precipitously after the 1
hour in vitro (Goodman, 1981).
GH has been reported to have no lipolytic effects in rabbit (Bowden
et al. 1985; Barenton et al. 1984), swine (Walton and Etherton, 1986), cattle
(Peters, 1986; McDowell et al. 1987), chicken (Duquette et al. 1984), reindeer
(Larsen and Nilssen, 1985), and human adipose tissue explants (Nyberg and
Smith, 1977). Species differences may account for some of these findings;
rabbit fat, unlike that of other species, is insensitve to isoproterenol (Fain 
al., 1984) as well as GH, but it is 10 times more sensitive to lipotropin than
rat fat (Lis et al. 1972). Other findings are inconclusive and most of the
negative findings require critical re-evaluation. Although no effects of GH
on lipolysis were observed in cultured swine fat (Walton and Etherton, 1986),
no glucocorticoids were present and the culture conditions were such that the
basal rate of lipolysis was 4 times higher than the maximum seen in rat fat.
No data were included to demonstrate that these explants were sensitive to
any lipolytic agent. In explants of bovine fat (Peters, 1986), mean rates of
glycerol production were higher in some groups of tissues treated with GH
but with only 3 or 4 observations per group, statistical significance was not
achieved. Lipolytic effects of GH on human adipose tissue were sought only
in fragments of subcutaneous fat that had been cultured for 7 days with or
without GH (Nyberg and Smith, 1977). These conditions may not have been
optimal for demonstrating an increase in lipolysis in response to any agent
since basal lipolysis was 4-25 times higher than in freshly isolated human
subcutaneous adipocytes (Ostman et ai., 1979). Responsiveness to other
lipolytic agents was not examined in these studies.
Except for rabbits, which have anomalous responses to lipolytic
agents in general, available evidence against a direct lipolytic effect of GH in
humans and farm animals is not convincing. A survey of the literature
revealed only one study of the effects of GH in human adipose tissue (Nyberg
and Smith, 1977) and its conclusions are at odds with a wealth of data that
support a lipolytic action for GH in vivo (Davidson 1987; Press, 1988).
Because the lipolytic effect of GH is small in contrast to that of catecholamine
its successful demonstration in vitro requires careful optimization of
experimental conditions with respect to the incubation medium,
maintenance of low basal rates of lipolysis, and careful timing of the
measurement of hormone action.
Role of glucocorticoids
The mechanism of action of glucocorticoids has interested
investigators for over 50 years. Shortly after its role in carbohydrate
metabolism was established, Ingle (1952) recognized that the glucocorticoids
must be involved in a wide variety of seemingly unrelated processes and
postulated that they act as general hormones permitting key metabolic
processes to achieve maximal rates.
Glucocorticoids are required for maximal metabolic rates of
gluconeogenesis (Exton et al. 1972), glycogenolysis (Stalman and Laloux
1979), glycogenesis (Plas and Nunez, 1976), and lipolysis (Fain, 1979). Since
glucocorticoids are not direct agonists for these processes, the idea of a
permissive role of glucocorticoid hormones evolved. The concept of
permissi action accounts for the observations that physiologic
concentrations of glucocorticoids hormone that have no stimulatory or
inhbitory effects on a specific process per se but nevertheless "permit" a
maximal response to another hormone or stimulus.
The mechanism of action of glucocorticoids has been studied
extensively (for review, see Baxter and Rousseau, 1979; Yamamoto, 1985) and
appears to involve the binding of glucocorticoid to a glucocorticoid receptor
located in the cytosol. The ligand-receptor complex translocates into the
nucleus which then binds to DNA on specific DNA sequences called
glucocorticoid response elements. Binding to DNA initiates transcription of
mRNAs and eventually to translation and protein synthesis.
In addition to affecting processes in the nucleus, glucocorticoids
have also been demonstrated to amplify the effects of non-steroid hormones.
Glucocorticoids have been shown to amplify the rates of glucagon-
adrenaline-, ACTH, and GH-induced lipolysis. Yet the fact that
glucocorticoids can amplify the effects of these hormones which presumably
act through a cyclic AMP-mediated process suggest that the signal
transduction pathway for glucocorticoids and peptide hormones may
converge at some point.
The mechanism of the steroid-cyclic AMP interaction is unknown
and although one or more steps in the action of these compounds could be
involved, most studies have focused on the pathway through which cyclic
AMP acts. Possibilties which could be involved include (1) regulation of the
intracellular level of cyclic AMP, (2) regulation of the action of cyclic AMP
and (3) interaction through a steroid dependent product.
lation of intracellular c clic AMP le
Glucocorticoids could enhance the action of cyclic AMP by allowing
an increase in the intracellular concentration of this nucleotide if levels of
cyclic AMP were limiting. However, data in the literature (Honnor et al.
1985) and to be presented in this thesis indicates that, at least for lipolysis, the
rate limiting component is the hormone sensitive lipase. If cyclic AMP were
not rate-limiting, a cyclic AMP-mediated pathway may stil be amplified by
increasing the pre-existing levels of cyclic AMP. However, Granner et ai.,
(1968) have shown that glucocorticoids alone did not increase cyclic AMP
production in liver cells after 4 hours of treatment. It is possible that
glucocorticoids do not increase cellular levels of cyclic AMP per se but rather
create conditions which promote the accumulation of cyclic AMP produced
by other hormones. Such a condition may arise if glucocorticoids inhibit
phosphodiesterase activity. Although glucocorticoids have been
demonstrated to inhibit phosphodiesterase activity in liver cells, the
inhbition was not sufficient to allow for cyclic AMP accumulation (Granner
et aI. 1975). Thus cyclic AM generation or degradation does not seem to be
involved in the permissive effect of glucocorticoids.
The glucocorticoid and cyclic AMP pathway is thought to converge
at some point although the exact point is unknown. There is evidence,
however, that the site of interaction is distal to cyclic AM. Friedman et al.,
(1969) showed that the stimulatory effect of glucagon on gluconeogenesis
noted in intact animals was not obtained in livers of adrenalectomized rats
despite that fact that identical increases in cyclic AMP were achieved in both.
Schaeffer al. (1969) postulated that the metabolic lesion in
adrenalectomized rats lies beyond adenylyl cyclase, since cyclic AMP was
unable to activate phosphorylase in the liver of such animals. This result
was confirmed in a perfused liver system by Exton et al., (1972) who showed
that, although the levels of cyclic AMP achieved by perfusing glucagon or
adrenaline through livers from normal or adrenalectomized rats was
normal, gluconeogenesis and glycogenolysis were impaired. These authors
also showed that lipolysis was markedly blunted in adipose tissue from
adrenalectomized rats (Exton et al., 1972). Also, induction of tyrosine
aminotransferase required pretreatment with dexamethasone although
dexamethasone had no effect on basal levels of intracellular cyclic AMP
(Granner et al. 1975) further supporting the notion that glucocorticoids act
distal to cyclic AMP accumulation.
Regulation of cyclic AMP action
There are several ways in which changes in the activity of the cyclic
AMP-mediated pathway could occur in the absence of a change in cyclic AMP
levels: (1) The amount of the regulatory subunit of protein kinase A or its
affinity to cyclic AMP may change. (2) The amount of the catalytic subunt or
its Km of activation by Mg++ ATP could change. (3) Protein kinase could be
activated in vivo by changes in distribution of cyclic AMP, and/or kinase
translocation. Finally, (4) the activity and/or amount of protein kinase
inhbitor may be changed.
If the affinity to cyclic AMP were to increase in the presence of
glucocorticoids, then one would expect pretreatment with glucocorticoids to
increase dibutyryl cyclic AMP actions. This was not the case as reported by
Fain (1968). Pretreatment of fat cells for 2 hours with dexamethasone failed
to potentiate dibutyryl cyclic AMP-induced lipolysis which would argue
against the possibilty that dexamethasone increases sensitivity of protein
kinase A to cyclic AMP. Although no one has looked at whether
glucocorticoids could change the number of cyclic AMP binding sites to the
number of protein kinase A catalytic subunits, there is evidence to indicate
that the total kinase activity within liver cells (Rousseau and Werenne, 1976)
and fat cells (data to be presented) is unchanged. Also, if glucocorticoids were
able to alter Knv then a given amount of cyclic AMP should be more effective
in the presence of glucocorticoids but again this was not the case (Granner 
al. 1977; Rousseau and Werenne, 1976). Thus the first 2 possible actions of
glucocorticoid on cyclic AMP-dependent protein kinase seems unlikely.
Does dexamethasone promote protein kinase translocation?
Translocation of protein kinase activity has been suggested to occur in heart
(Corbin et ai. 1977) and liver (Rousseau et ai., 1976) and is a potential
mechanism of control. Such a mechanism could be accomplished without
significant changes in the intracellular concentration of cyclic AMP. Corbin
et ai. (1977) demonstrated that the rabbit heart protein kinase associated with
the particulate fraction. Addition of cyclic AMP causes cytosol catalytic
activity to increase, with a corresponding decrease in activity in the
particulate fraction. The authors use this data to postulate a model for the
hormonal control of the compartmentalization, and activation, of protein
kinase A (Corbin et ai. 1977). However , Rousseau et aZ. (1976) had studied
the intracellular distribution of protein kinase A in liver and found it to be
the same in intact and adrenalectomized rats. Re-administration of
glucocorticoids did not change the distribution of protein kinase A and thus
does not appear likely that protein kinase A translocation is involved in the
interaction of glucocorticoids and cyclic AMP.
Does dexamethasone modulate protein kinase A activity through an
inhbitor? In addition to regulation by cyclic AMP, protein kinase A can be
modulated by a heat-stable protein kinase inhibitor (Walsh et al. 1971). This
protein kinase A inhibitor appears to inhbit catalytic activity by binding to
free catalytic subunits and inhbiting its enzymatic activity. Glucocorticoids
could indirectly influence kinase catalytic activity by altering the amount of
this inhbitory protein or the kinetics of binding of cyclic AMP to protein
kinase A. However, the observation that kinase activation by cyclic AMP is
identical in control and dexamethasone-treated cells argue against a
regulatory effect of glucocorticoids via an inhbitor. As well, levels of the
heat-stable protein kinase inhibitor appear to be unchanged with
dexamethasone stimulation (Ashby et al., 1977).
Interaction throu h a steroid de endent roduct
Other actions of glucocorticoid require a lag time presumably to
allow for RNA and protein synthesis. Adrenalectomized animals has been
shown to have blunted hyperglycemic response to adrenaline.
Administration of cortisol to these animals for 3 days restored the
hyperglycemic response to adrenaline where an injection of cortisol only 15-
20 min before adrenaline failed to restore the hyperglycemic response
(Schaeffer et ai. 1969). This lag suggests that glucocorticoids induces the
..1
synthesi of proteins for the hyperglycemic response. This finding supported
the earlier finding by Fain (1967) in which he demonstrated that inhbitors 
RNA and protein synthesis prevented the lipolytic actions of
GH/Dexamethasone. Thus it seems the augmentation of the cyclic AMP-
mediated pathway requires RNA and protein synthesis.
Finally, an additional mechanism by which glucocorticoids may
potentiate the cyclic AMP pathway without activating it is by removal of
tonic inhbition. Kather et ai., (1985) had shown that, in vivo, fat cells are
under predominantly inhibitory control and prostaglandins was shown to be
one of the inhibitory agents but did not address the question as to the source
of the prostaglandin. Parker et al. (1989) had found that isolated adipocytes
were unable to synthesize prostaglandin E2 but a more recent finding by
Richelsen et al. (1992) have shown that adipocytes do indeed synthesize
prostaglandins.
Lewis and Piper (1975) had shown that glucocorticoids could inhibit
the release of prostaglandins. By preventing the release of prostaglandins,
glucocorticoids could potentiate the lipolytic effect of GH. In addition to
preventing the release of prostaglandins , glucocorticoids have also been
shown to have a potent blocking action on prostaglandin biosynthesis
(Flower et aI 1972). It was eventually demonstrated that the blocking action
of glucocorticoids was prevented by inhibitors of protein synthesis (Flower
and Blackwell, 1979). Eventually the protein which inhbited prostaglandin
synthesis was identified (Blackwell et ai. 1982) and named lipocortin (Di Rosa
et al. 1984). Lipocortin inhibits prostaglandin biosynthesis by inhbiting the
enzyme phospholipase A2 which catalyses the formation of arachidonate, a
precursor to prostaglandins. Thus glucocorticoids have a double action in
suppressing prostaglandin action: inhibition of its synthesis and release, both
of which can potentially augment the cyclic AMP-mediate pathway in 
hormone response without actually triggering the cyclic AMP cascade.
proteins
tein cou led rece tors
Before exploring the different mechanisms by which GH may
transduce its signal for lipolysis, it may be useful to review what is known
about the receptors and signallng mechanisms for the more extensively
studied lipolytic agents such as catecholamine.
Catecholamine receptors, which belong to a superfamily of
glycoprotein receptors that consist of approximately 400-600 amino acids
incl ude receptors for adrenergic, dopaminergic, muscarinic, and
serotoninergic ligands. Peptide hormone receptors in the same superfamily
include tachykinins, glucagon, and somatostatin to name a few (for review
see Dohlman et al. 1991). The most notable feature of this superfamily is the
presence of 7 stretches of 24-28 predominantly hydrophobic amino acids
arranged in a-helical structures that are thought to represent transmembrane
domains by analogy with the known secondary and tertiary structure of
bacteriorhodopsin (Henderson and Unwin, 1975). Thus it appears that these
molecules thread back and forth through the cell membrane such that there
are 4 extracellular regions and 4 intracellular regions. The amino acid
homologies among the members of this gene family are greatest within the
transmembrane domains at., 1991). The putative(Dohlman 
transmembrane domains are connected by alternating extracellular and
intracellular domains (Wang et ai. 1989). The amino termini of G protein-
coupled receptors are extracellular and contain sites for N-linked
glycosylation while the cytoplasmic domains contain potential sites for
phosphorylation. The C-terminus and the cytoplasmic segment between
helices V and VI form domains that interact with G proteins. It now appears
likely that any receptor that interacts with G proteins contains these key
structural features (Figure 2).
Since most lipolytic agents utilize the cAMP-dependent pathway,
which is regulated by G proteins, and because G proteins are potential targets
for GH action it may be useful to review the current understanding of these
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Shared features of receptors coupled to G proteins. The model ilustrates
some of the features predicted to be shared by all reeptors that interact
with G proteins. About hal the residues ar proposed to fQnn seven
transmembrane helices which appear to form the agonist binding pocket.
Varable numbers of the extracellular asp residues in the N-tenninal tal
are glycosylated and in the intracellular C- tenninal tail , several serine
and threonirie -resi-dues may be phosphorylated. Some of the regions
proposed to interact with G proteins are also shown. (Taken from
Taylor, 1990)
ubiquitous regulators. In 1971, Rodbell and co-workers demonstrated that the
hormone glucagon (which exerts its effects through adenylyl cyclase) and its
receptor are not sufficient to activate adenylyl cyclase. The nucleotide
guanosine triphosphate (GTP) had to be present too (Rodbell et al., 1971).
This finding ultimately led to the discovery of the family of GTP-binding
proteins, now known as G proteins, which playa pivotal role in transducing
a wide variety of extracellular stimuli into intracellular responses. G proteins
may transmit signals that stimulate or inhibit adenylyl cyclase and are
accordingly designated G or Gi. It was subsequently found that G proteins
also regulate other effectors besides adenylyl cyclase including phospholipase
C and ion channel proteins (Cockcroft and Gomperts, 1985; Breitwiesser and
Szabo, 1985). These G proteins are heterotrimers that consist of a, p, and y
subunits, of molecular mass 36-52, 35-36, and 6-8 kD, respectively and are
believed to be bound to the cytoplasmic face of the membrane bilayer
(Gilman, 1987). Regulation of adenylyl cyclase is mediated primarily by the a
subunits which are therefore designated Gia or Gsa. P and y subunits are
shared by Gsa and Gia. To date, molecular cloning techniques have
identified in mammalian tissues more than 17 different a subunits, 4 p
subunits, and 4 y subunits (Simon et al. 1991). Rat adipocytes express three
forms of inhibitory G proteins (Gi1 , Gi2, Gi3) which are distinct gene products
(Mitchell et ai. 1989; Miligan, 1988). Some investigators have suggested
Gia2 as the Gia species responsible for the inhibition of adenylyl cyclase
(McKenzie and Miligan, 1990; Simonds et al. 1989). Rat adipocytes also
express two isoforms of G (42 and 45 kD), which are derived from a
single gene product by alternative splicing of mRNA (Strassheim, 1991, 1990;
Robishaw et al. , 1986).
The and 'Y subunits form a 'Y complex, which can only be
dossociated under denaturing conditions. The major function of the 
complex appears to be the formation of the G protein trimeric complex
which constitutes the inactivated state of the protein. There is also some
evidence that 
'Y complexes may playa role in anchoring a subunits to the
membrane (Sternweis, 1986). More recently, the 
'Y complex has also been
implicated as a mediator of intracellular signals such as activation of
phospholipase A2 (Kim et al. 1989; Axelrod et ai. 1988; Jelsema et al., 1987),
adenylyl cyclase (Federman et al. 1992; Tang and Gilman, 1991), and the
mating response in yeast (Whiteway et al. 1989). Although the different G
proteins have traditionally been defined by their a subunits, the recent
discoveries of greater numbers of and 
'Y subunits complicate this picture.
',".
Signal transduction processes known to be mediated by G proteins
include the hormone- and neurotransmitter-mediated regulation of adenylyl
cyclase, phosphoinositide-derived second messengers and ion channels and
activation of sensory systems including vision, olfaction, and taste. The
molecular mechanism of G protein-mediated signal transduction has been
elucidated in two systems: the hormone-stimulated increase in adenylyl
cyclase activity and the light-stimulated phototransduction cascade in retinal
rod cells (Neer and Claphman, 1988; Gilman, 1987).
The disaggregation theory, first proposed by Rodbell (1980) describes
the mechanism by which G proteins may transduce hormonal signals. This
theory suggests that a wide variety of receptors are coupled with a family of
G proteins. In the resting state, G proteins, which consist of a y subunits, are
associated with GDP. When a hormone binds to its G protein coupled
receptor, G protein exchanges its bound GDP for GTP, and becomes activated.
The G protein heterotrimer then dissociates into the free a monomer and the
y dimer. The GTP-bound a subunit then diffuses to and binds to an effector
(eg: adenylyl cyclase or ion channel) and activates it. After a few seconds, the
a subunit, which has intrinsic GTPase activity, converts GTP to GDP thereby
inactivating itself. The inactivated a subunit then re-associates with the 
complex and resumes the resting state.
In spite of the extensive knowledge of G protein structure and
actions, understanding of the topological relationship between receptors, G
proteins and effectors, and their relative stoichiometry is limited. It is not
even known whether the quantitative relationship between individual
components of the G protein signallng pathway changes. There is evidence
that G proteins are not confined to the inner surface of the membrane (Garty
et al., 1988). Those attached to the membrane are activated by hormones.
Tolkovsky and Levitzki (1978) proposed a "collision-coupling" model in
which the rate of adenylyl cyclase activation is proportional to the frequency
and efficiency of collsions between agonist-bound receptor and G protein. In
this way, a receptor may activate a number of G proteins due to the free
mobilty of each component. Although receptors may interact or "collde
with more than one G protein, each type of receptor interacts with a specific
subtype of G protein. For example, stimulatory receptors interact exclusively
with stimulatory G proteins.
important characteristic of protein-mediated signal
transduction is the abilty to amplify the primary signal (Gilman, 1987). For
most systems, amplification is achieved in two stages: (1) the activation of 
to several hundred G proteins by a single ligand bound receptor, and (2) the
turnover of thousands of second-messenger molecules by each activated
effector enzyme (Gilman, 1987). In this way, the signal carried by a single
ligand molecule may by amplified by more than 10,000-fold.
The function of many proteins is determined by the covalent
addition of a variety of molecular entities to their polypeptide chains. Post-
translational modifications may serve to target a protein to its cellular
location or it may regulate its activity. Such modifications may be as simple
as addition or removal of a phosphate group or addition of constituents as
large and complex as glycophospholipid moieties. large number of
modifications which include prenylation, acylation, phosphorylation, and
ADP-ribosylation may affect G proteins. Prenylation and acylation involves
the attachment of a hydrophobic side-chain to the G protein allowing it to be
anchored or attached to the plasma membrane. Prenylation involves the
transfer of an isoprenoid moiety to a cysteine residue near the carboxyl
terminus of the y-subunit (Yamane and Fung, 1993) followed, in some cases,
by proteolysis of three terminal residues to yield a carboxyl-terminal prenyl
cysteine. Acylation is a more general process and typically includes the
attachment of a myristate or palmitate group to a and y subunits (Yamane
and Fung, 1993). The two prominent acylation reactions are myristoylation
and palmitoylation. In myristoylation, a myristat group is attached to an
amino terminal glycine, a process that appears to be cotranslational and
irreversible. Myristoylation of a subunits appears to increase the apparent
affinity of a subunits for the y complex or for effector molecules, and to
facilitate association with cellular membranes (Mumbyet a!., 1990; Linder eet
al. 1991; Taussig et al. 1993; Jones et al. 1990). In contrast, palmitoylation
occurs on cysteine residues' of a subunits , is posttranslational and reversible
(Roach, 1991; Edelman et al. 1987) and may function to regulate activity and
. membrane association of a subunits (Linder et a!. , 1993)
The functional activity of G proteins may also be regulated by
phosphorylation. Phosphorylation of Gi probably catalysed by protein kinase
C (Martin et al. 1992; Sagi-Eisenberg, 1989; Katada et al. 1985) diminishes its
abilty to inhibit adenylyl cyclase (Pyne et al. 1989; Katada et al. 1985). The
enhanced abilty of glucagon to increase cyclic AMP in livers of diabetic rats is
associated with increased phosphorylation of G a2 (Bushfield et al. 1990) but
the amounts of the G proteins are unchanged (Allard et a!. 1991; Bushfield 
al. , 1990).
ADP-ribos lation
ADP ribosylation differs from other modifications in that G proteins
do not appear to be ADP-ribosylated under normal physiological conditions.
ADP-ribosylation does occur in vivo when cholera toxin and pertussis toxin
from the bacteria Vibrio cholerae and Bordetella pertussis, catalyse ADP-
ribosylation of G & Gi a subunits. ADP-ribosylation involves the transfer of
an ADP-ribose moiety from NAD+ to an acceptor residue, such as arginine,
cysteine, or asparagine. The resulting ADP-ribosylated protein loses its abilty
to cycle between active and inactive forms.
ADP ribosylation catalysed by either cholera toxin or pertussis toxin
is a useful tool for identifying which G proteins might participate in a process
and for manipulating a process experimentally. Cassel and Selinger (1977)
were the first to identify the component that regulates adenylyl cyclase, later
known as as the substrate for ADP-ribosylation by cholera toxin and
deduced that ribosylation of G blocked the intrinsic GTPase activity of Gs
(Cassel and Selinger, 1978) rendering it constitutively active.
Pertussis toxin-mediated ADP-ribosylation affects a distinct subset of
G protein a subunits, Gia, Go a (olfactory) and Gta (transducin) (Katada et al.
1986; Van Dop et al. 1984; Manning et al. 1984; Watkins et al. 1984; Sternweis
and Robishaw, 1984). The ADP-ribosylation of G proteins by pertussis toxin is
most efficient when the a subunit is in the a y heterotrimeric form (Moss
and V;lughan, 1988). ADP-ribosylation blocks the interaction of the a
subunits of the inhibitory G proteins with their receptors, thereby blocking
the receptor mediated exchange of GDP for GTP (Cote et al. 1984; Murayama
and Vi, 1983). As a result, inhbition of adenylyl cyclase is relieved, leading to
elevation in cellular concentrations of cyclic AMP.
nist-re ula els d d but G p ote
The relative abundance of G proteins, and their subtyes is a source
of debate, but there is now evidence that levels of G proteins within cells are
not fixed and may change depending upon prevailing physiological
conditions (Miligan and Green, 1991; Miligan, 1993). If G proteins are or can
be made to be the limiting component for the action of a transmembrane
signallng cascade, then they provide an additional locus for regulation of
desensitization (Miligan and Green, 1993). In the few cases reported, simple
measurements of the levels of G proteins suggest the G proteins are present
in substantially greater abundance than adenylyl cyclase. For example, it has
been calculated that there is 30-80 times more Gsa than adenylyl cyclase in
S49 lymphoma cells (Levis and Bourne , 1992; Alousi et al. 1991). It thus
might seem that even substantial down-regulation of G proteins would be
unlikely to limit maximal responsiveness. However, agonist induced down-
regulation of G proteins often correlates with development of a so-called
heterologous desensitization (Miligan and Green, 1993) in which a decrease
in Gia is associated with a concomitant increase in Gs , or vice-versa
depending on the agonist. For example, in rat white fat cells, chronic
treatment with phenylisopropyladenosine (PIA) or prostaglandin El
produced a time- and dose-dependent down-regulation of the relative
amounts of membrane-associated a subunits of Gi1 , Gi2, and Gi3 while
increasing levels of Gs a (Green et al. 1990, 1992). These changes occurred
without any changes in the mRNAs for these proteins suggesting regulation
at the translation or degradation levels. Loss of Gia was detectable within 24
hours (Hadcock et ai. 1991; Green at aI, 1990) of incubation of adipocytes with
the adenosine receptor agonist. Conversely, inactivating Gi by treating rats
with pertussis toxin for 3 days doubled Gial and Gia2 without changing Gs
(Ramkumar and Stiles, 1990). Hypothyroidism also decreased Gia in
adipocytes (Ros et al. 1988; Milligan et al. 1987), while adrenalectomy
decreased Gs a and the subunits common to both G and Gi (Ros et al.
1989a b ).
An alternate means of regulating the functional activity of G
proteins may be to control the relative amounts of Gi and in the vicinity of
adenylyl cyclase. G protein subunits have been shown to partition from
plasma membranes to cytosol in response to physiological changes in some
experimental models. Stimulation of human platelets with adrenaline
resulted in a shift of Gia2 from a detergent-soluble fraction, presumably
membranes, to a detdgent-insoluble cytoskeletal fraction (Crouch et al., 1989).
Human neutrophils subjected to a mild degranulating stimulus responded
with a shift of Gi from the granule fraction to the plasma membrane fraction
(Rotrosen et a 1., 1988). Stimulation of rat adipocytes with a high
concentration of isoproterenol produced a shift in the distribution of Gia2,
a, and adenylyl cyclase from heavier plasma membranes to less dense
membranes thought to represent pinocytic vesicles (Haraguchi and Rodbell
1990).
Treatment of membranes with analogs of GTP (eg: GTP)') with or
without a relevant agonist, can cause a time- and dose-dependent "release" of
proteins from the membrane fraction to the soluble fraction (Miligan and
Unson, 1989). Such agonist-induced G protein partitioning from membrane
to the soluble fraction would appear to require that the affinity of interaction
of the G protein a subunit with the membrane be reduced (Levis and Bourne,
1992). A possible mechanism for such a regulatory process may be a change
in the fatty acylation status of the subunit. For example, since
palmitoylation is reversible and occurs with both G and Gi, agonist-induced
membrane release of proteins may involve depalmitoylation.
Palmitoylation is thought to anchor G protein a subunits to the plasma
membrane (Mumby et al., 1994). Such a mechanism could conceivably
result in reduced abundance or accessibilty of Gia2 or Gsa in the vicinity of
adenylyl cyclase and thus affect cyclic AMP production in response to agonist.
oss ible rowth hormone si nalln hanism
Great strides have recently been made in our understanding of GH
action. The human GH receptor is a 620 amino acid single chain protein
containing a glycosylated 246 amino acid extracellular hormone-binding
domain, a single 24 amino acid transmembrane domain, and a 350 amino
acid cytoplasmic domain. The GH receptor is a member of the
GH/prolactin/ cytokine/hematopoietin receptor superfamily (Cosman et al.
1990; Bazan, 1990) which also includes receptors for interleukins (IL)- , IL-
IL- , IL-6, IL- , granulocyte-macrophage colony-stimulating factor (GM-CSF),
erythropoietin, ciliary neurotrophic factor, leukemia inhibitory factor, and
interferons a, p, and y. Although there is relatively little overall homology
between these receptors, members of this receptor family possess in the
extracellular region, 4 conserved cysteine residues which form 2 disulfide
loops, a 7 amino acid proline-rich sequence and a peptide consensus
sequence, the so-called WSXWS motif
, which is less conserved in the GH
receptor, (Cunninghan et ai. 1991; Colosi et al., 1993).
Growth hormone promotes the phosphorylation of its 
receptor on
tyrosyl residues (Foster et al. 1988) but unlike the insulin receptor (Becker
and Roth, 1990; Wente and Rosen
, 1990), the GH receptor has no intrinsic
tyrosine kinase activity (Colosi et al. 1993; Carter-Su et al. 1989). The recent
/--
identification of JAK2 as a GH receptor associated tyrosine kinase
(Argetsinger et al. 1993) may resolve some of the issues of phosphorylation
, .
without tyrosine kinase activity. JAK2 is a member of the Janus family of
tyrosine kinases which have both a catalytic tyrosine kinase domain and a
tyrosine kinase-like region (Harpur et ai. 1992). Of particular importance are
the observations that JAK2 also associates with other members of the
cytokine/hematopoietin receptor superfamily including the 
receptors for
erythropoietin
, interleukin- , GM-CSF, and prolactin and may transduce
their signals (Argetsinger et ai. 1993). Thus it appears that the members of
this receptor superfamily exhibit at least one common signallng pathway.
Signallng cascades involving protein kinase C have also been
implicated in some actions of GH although the connection between the GH
receptor and phospholipase C is unknown. 
Acridine orange, an inhibitor of
protein kinase C
, blocked the stimulation of lipogenesis by GH in rat
adipocytes (Smal and De Meyts
, 1989). Sphingosine, another protein kinase C
inhibitor, suppressed the insulin-like actions (increased glucose uptake,
lipogenesis) of GH in rat adipocytes (Smal and De Meyts, 1989). Studies by
Gorin et al. (1990) showed that sphingosine and staurosporine, yet another
protein kinase C inhibitor, blocked the lipolytic effects of GH in tissues of
both normal and hypophysectomized rats. Gorin et aZ. (1990) also showed
that phorbol 12-myristate 13-acetate (PMA), a protein kinase C activator, was
lipolytic, but its lipolytic effect was additive with the maximal lipolytic
response of GH suggesting that activation of protein kinase C does not
account for the lipolytic response to GH.
In unrelated studies induction of c-fos by GH in a mouse 3T3
adipocyte cell line appeared to be mediated in part by activation of protein
kinase C (Doglio et ai., 1989; Slootweg et al. 1990). One of the earliest events
in the actions of many hormones and growth factors is the induction of early
response proto-oncogenes. Growth hormone stimulates the induction of the
c-myc proto-oncogene in the liver and kidney of hypophysectomized rats
(Murphy et al. 1987) as well as c-fos in OB1771 mice cells (Doglio et al., 1989).
Furthermore, continuous GH infusion has been shown to modulate the
expression of c-myc and c-fos during early stages of rat liver carcinogenesis
(Hallstrom et ai. 1989). Growth hormone has also been shown to rapidly and
transiently induce the expression of c-fos and c-jun mRNA in preadipocytes
(Gurland et ai. 1990). This induction was inhibited by prolonged incubation
with phorbol ester to deplete protein kinase C suggesting that GH induction
of c-fos and c-jun may involve diacylglycerol and protein kinase C.
Despite recent progress in the understanding of early reactions in
the GH signallng pathway, the cellular mechanisms that account for the
lipolytic actions of GH are unknown. There is no evidence for a direct
interaction between the GH receptor and G proteins, but nevertheless it is
likely that GH acts by way of the cyclic AMP-dependent pathway (Goodman 
al., 1988). After treatment of adipocytes with GH, small increases in cyclic
AMP were observed by some investigators (Fain and Saperstein, 1970,
Moskowitz and Fain, 1970) but not others (Sengupta et al. 1981; Harris and
Bennun, 1976). Glycogen phosphorylase, whose activity depends upon cyclc
AMP in a manner similar to hormone sensitive lipase was also activated by
GH/Dex treatment after a delay of about 2 hours (Eisen and Goodman, 1969;
Moskowitz and Fain, 1969). Inhbition of cyclic AMP breakdown potentiates
the lipolytic action of GH (Goodman, 1968a, 1968b; Fain, 1968 1967), consistent
with a role for cyclic AMP. If lipolysis induced by GH/Dex does indeed utilze
the cyclic AMP dependent pathway, the actions of GH/Dex must precede
protein kinase A activation since responsiveness to dibutyryl cyclic AMP and
bromo-cyclic AMP are unchanged in tissues treated with GH/Dex (Fain
1968; Goodman, unpublished data)
Although GH may not interact with G proteins directly, it is possible
that G proteins are targets of GH induced proteins. As already discussed, the
amounts or activities of G proteins are not constant and appear to be
regula ted ph ysiologicall y. Studies by Goodman et ai., (1988) have
demonstrated that in the absence of GH (eg: hypophysectomy), Gi levels, as
determined in studies of pertussis toxin catalysed ADP-ribosylation, increase
and upon administration of GH, Gi levels decrease. More recently, Doris 
aI., (1994) have shown GH to decrease the response to anti-lipolytic agents
(PIA and prostaglandin El) and decrease the levels of Gi2 in rat adipocytes. As
well, Roupas et al., (1991) found that GH treatment of adipose tissue inhibited
ribosylation by pertussis toxin (-60% inhibition) suggesting that the effect
involves a large portion of pertussis toxin-sensitive G proteins.
ectives
The objective of the research in this dissertation is to gain insight
into signallng mechanisms by which GH increases lipolysis. To this end we
tested the hypothesis that the increase in lipolysis induced by GH occurs
through a cyclic AMP mediated pathway. We propose that GH acts to
increase intracellular cyclic AMP levels thereby activating protein kinase A
with the consequent activation of the hormone-sensitive lipase and lipolysis.
As our studies progressed, other hypotheses were formulated and tested as
discussed in subsequent sections.
We approached this study by examining cellular and biochemical
events that occur in fat tissue and adipocytes in response to GH. Growth
hormone has been shown to activate several signal transduction pathways in
adipocytes including tyrosine kinase (Argetsinger et al. 1993), protein kinase
C (Gorin et al. 1990) and the cyclic AMP-dependent pathway (Goodman et al.
1988) all of which may or may not be interrelated since, for example,
activation of JAK2 is very rapid (within minutes) while activation of lipolysis
may occur only after a delay of several hours. Although the cyclic AMP-
mediated events may be the immediate events prior to lipolysis, the events
between it and the receptor are not known and are explored in this thesis.
We elected to study GH effects on the cyclic AMP-dependent
pathway because it was most likely to be involved in lipolysis. Parallel
studies into the lipolytic effect of GH and isoproterenol, a catecholamine
analog, was performed to compare the lipolytic effects of GH with what is
known about lipolysis by catecholamine.
Materials and Methods
Animals- Normal male rats of the Charles River CD strain
(Charles River Breeding Laboratories, Kingston NY) were used in all
experiments in accordance with protocols approved by the UMMC Animal
Care and Use Committee. Rats were fed Purina 5008 (Ralston-Purina, St.
Louis, MO) from the time they were received until they were studied 1-
weeks later and had attained a body weight of 180-250 g. The rats were
maintained at constant temperature (23 C) and lighting with lights on from
0600-1800 h. Rats were killed by cervical dislocation and epididymal and
perirenal fat pads were removed.
lncubations- Thin distal portions of epididymal fat pads (--100 mg),
or isolated adipocytes (Rodbell, 1964) from epididymal and perirenal depots
were incubated (1:10 dilution) in Krebs Ringer bicarbonate-buffer (pH 7.4) that
contained 5.5 mM glucose (KRBG) and 1% w /v bovine serum albumin (BSA)
(Introgen Co. NY). Incubations were carried out in a shaking water bath
(3TC) under an atmosphere of 95% 02/ 5% C02 for 4 hours When
indicated, the following were added to incubation media: 30 ng/ml human
GH (hGH; Genentech Corp., San Francisco, CA), 1 Jlg/ml dexamethasone (9a-
fluoro- 11 17 a-trihydroxy-16a-methyl- pregnadiene- 20-dione; Lypho-
; ;
Med, Inc., Chicago, IL), 0.1 ng/ml or 1 Jlg/ml (I)-isoproterenol (both with
added 100 Jlg/ml ascorbate), 100 JlM colchicine, 30 JlM Rp-CAMPS (a
generous gift from Dr. Bell of Sandoz Inc. , NJ), or 2 Jlg/ml pertussis toxin
(List Biological; Campbell, CA). All other reagents were obtained from Sigma
Chemical Co. (St. Louis, MO).
Tissue or Cell Homo enization and Membran Puri cation- Unless
otherwise indicated, all tissues and cells were homogenized in 2 volumes of
homogenization buffer (10 Tris-HCI 7.4;
ethylenediaminetetracetic acid (EDT A); 100 mM phenylmethylsulfonyl
fluoride (PMSF); 10 Jlg/mlleupeptin) at 4 C in ground glass homogenizers
with 10 up/down strokes. The homogenates were allowed to settle for 
min in an ice bath until a fat cake formed. After removal of the fat cake the
infranatants were used to prepare purified membranes or were assayed for
cyclic AMP content or protein kinase A.
Plasma membranes were purified from homogenates of isolated
adipocytes according to procedures developed by McKeel and Jarret (1970).
Briefly, homogenates were centrifuged in an SS-34 rotor in a Sorval(! RC2-
centrifuge (Du Pont, Wilmington, DE) at 12 000 rpm (.. 16k x 
g) 
for 20 min.
The resulting pellet is referred to as the 16k pellet" The remaining
supernatant was further centrifuged in a Ti 60 rotor in a Beckman(! L8-
Ultracentrifuge (Palo Alto, CA) at 50,000 rpm (.. 100k x 
g) 
for at least 1 hour to
obtain the " lOOk pellet". The 16k and lOOk pellets were assayed for adenylyl
cyclase activity (Salomon et al. 1974), or studied by Western immunoblot
analysis (Towbin et al. 1979). In some experiments, the 16k pellets were
resuspended in 1 ml and layered over linear sucrose density gradients (5-25%)
and centrifuged in SW41 rotor at 37 000 rpm (..100k xg) for 90 min. Fractions
were collected by pipetting successive 0.8 ml aliquots from the top. Hence,
lower fraction numbers represent lighter fractions while higher fraction
numbers represent denser fractions. The fractions were subsequently
analyzed for their content of G proteins or 5' -nucleotidase (see below).
West rn Blot Anal Both the 16k and lOOk pellets as well as Ii;:;!!ilJ
II:"
membrane fractions separated on sucrose gradients were solubilzed (mixed : I
1!iii
and shaken with Laemmli buffer (1970) for 1 hour at room temperature to i:!I!1:.':1
!jjj
mildissociate G proteins from membranes then boiled for 5 min before loading
on 10% sodium dodecyl sulfate polyacrylamide gels for separation by
electrophoresis (PAGE). After determining protein content (Lowry et al.
1951) all lanes containing 16k or lOOk samples were loaded with identical
amounts of protein. Samples were resolved by electrophoresis with a
Hoefer(B vertical electrophoresis apparatus (SE600; Hoefer, San Francisco, CA)
and transferred onto nitrocellulose (MSI, Westboro MA) by the method of
Towbin (1979) with a Hoefe transfer apparatus (TE42; Hoefer, San Francisco,
CA). Non-specific antibody binding sites on the membrane were blocked
with 10% milk proteins in phosphate buffered saline (PBS) for 2 hours at
room temperature followed by washing 3 times for 2 min, in PBS + 1% milk
proteins. Membranes were then incubated with rabbit anti-Gia2 diluted
1:1000 in PBS +1% milk proteins at 4 C for 2 hours and washed 3 times for 2
min and once for 20 min, in PBS + 1% milk proteins + 0.3% Tween 20.
Polyclonal antibodies directed at the C-terminal decepeptide of Gia2 (Lys-Glu-
Asn-Leu-Lys-Asp-Cys-Gly-Leu-Phe) or G a (Gln-Arg-Met-His-Leu-Arg-Gln-
Tyr-Glu-Leu-Leu) and characterized by Rapiejko et al. (1989) were a generous
gift from Dr. C. Malbon. Membranes were then re-incubated with
horseradish-peroxidase conjugated goat-anti-rabbit antibody diluted 1:10,000
in PBS + 1% milk proteins at 4 C for 2 hours followed by washing 3 times for
2 min, and once for 20 min, in PBS + 0.3% Tween 20. After soaking for 1 min
in ECL(I chemiluminescent reagent (Amersham; Arlington Heights, MO) to
allow for chemiluminescent detection of antibodies, membranes were
exposed to X-ray fim for between 5 seconds to 1 hour, depending upon the
intensity of luminescence. After development of the fim, membranes were
cleared of antibodies by soaking in stripping solution (60 mM Tris-HCl, pH
8; 2% w /v SDS; 0. 1 M -mercaptoethanol) for 30 min at C with
occasional agitation and were re-probed with anti- a under identical
conditions as described above. Bands representing G proteins were
quantitated by densitometry.
ADP- RiboS lation- Pertussis catalysed ADP-ribosylation was
performed according to methods described by Roupas et al. (1991). Briefly,
the reaction was carried out in 100 mM Tris-HCI (pH 8.0) containing 2 Jlg/ml
of activated pertussis toxin, 2 mM ATP, 25 mM dithiothreitol, 30-50 Jlg
proteins and 5 JlCi of (a--2P)NAD (specific activity 5 JlCi/Jlmole; Amersham
Arlington Heights, IL) in a total volume of 100 Jll. The ribosylation reaction
was carried out at 3TC for 30 min and terminated by addition of 50 Jll 2X
concentrated Laemmli buffer. Samples were solubilzed, boiled and resolved
on SDS-P AGE followed by autoradiography and quantitation by
densitometry. :1,
ASSA YS
cerol- Except where indicated, the rate of lipolysis was measured
as the rate of glycerol production during the 4th hour of incubation. One ml
aliquots of cell suspension or incubation media were removed at 180 min
and 240 min of incubation, filtered through glass wool to remove cells.
Samples of filtrate were assayed for glycerol content by the method of
Wieland (Wieland, 1957). The difference in glycerol content between 240
min and 180 min represents the amount of glycerol produced in the fourth hour.
clic AMP- Cyclic AMP was determined in duplicate by
radioimmunoassay according to the manufacturer s specifications using a kit
obtained from Amersham (Arglington Heights, IL). Samples were serially
diluted 100- to 1000-fold to obtain concentrations of cyclic AMP that fell
within the optimal detectable range of the radioimmunoassay.
Protein A- Protein kinase A was assayed by an adaptation of
the procedures of Roskowski (1983) and Corbin (1983). Replicate tissues (..100
mg) were homogenized in an equal volume of PKA homogenizing buffer (10
mM potassium phosphate, pH 6.8; 10 mM EDTA; 0.5 mM 1-methyl-
isobutylxanthine; 0.5 M NaCI) and centrifuged at 12 000 xg for 5 min at 4
25 Jll of infranatant (the aqueous phase) was added to the reaction mixture (50
mM morpholi opropanesulfonic acid (MOPS) pH 7.0, 10 mM MgCb,
mg/ml bovine serum albumin, 100 JlM kemptide (Sigma, St. Louis, MO), 100
JlM y32P-ATP (specific activity 5JlCi/Jlmol; Amersham, Arlington Heights,
IL), :t100 Jl cyclic AMP, distiled water) to give a final volume of 100 JlI and
incubated for 10 min at 37 C. 20 JlI aliquots of reaction mixture were spotted
within 2 cm X 2 cm squares, drawn out in pencil, on a sheet of Whatman P81
chromatography filter paper and the reaction stopped by washing 3X in 
mM phosphoric acid for 5 min and then with 95% ethanol. After drying at
room temperature, the individual squares were cut out and counted in
scintilation cocktail (Optifuo , Beckman Instruments). Protein content of
the infranatants was determined by method of Lowry et al. (1951). Data were
expressed as cpm/l0 Jlg protein/10 min or the ratio of specific activity of the
enzyme in the absence of 100 JlM cyclic AMP divided by maximally
stimulated activity in the presence of cyclic AM. The ratio thus represents
the degree of protein kinase A activation by hormone, henceforth referred to
as the activity ratio.
Aden l C clase- 50 JlI of 16k and lOOk pellets resuspended in
homogenizing buffer were mixed with 300 Jll of adenylyl cyclase assay
mixture (25 mM Tris-HCI, pH 7.4; 12.5 mM MgCI2; 20 mM creatine
phosphate; 250 U/ml creatine phosphokinase; 1 mM ATP; 100 JlM GTP) with
and without 1 mM forskolin (Okuda et al. 1992) and incubated at 30 C for 10
mIn. The reaction was terminated by addition of 50 JlI of 25% ice-cold
trichloroacetic acid (TCA) followed by centrifugation in an Eppendorf tabletop
centrifuge ( 16k x g) for 15 min. TCA was removed by extraction 3 times with
5 volumes of diethyl ethyl ether and the remaining aqueous layer was
assayed for cyclic AMP as described above. Data were expressed as pmol/ Jlg
protein/10 min or the ratio of enzyme activity in the absence and presence of
1 mM forskolin. The ratio thus represents the degree of adenylyl cyclase
activation by forskolin henceforth referred to as the activity ratio.
Nucl otida e Assa -nucleotidase was used as an enzyme
marker for the plasma membrane and was assayed with and without
j3-methyleneadenosine diphosphate (AOPCP), an agent that specifically
inhibits plasma membrane associated 5' -nucleotidase (Burger and
Lowenstein, 1970). Briefly, the reaction was carried out for 15 min at 3TC 
1 mlof 60 mM Tris-HCl (pH 7.4) containing 100 JlM ATP, 0.015 JlCi (U- 4C)5'
AMP (specific activity 0.2 JlCi/pmol; Du Pont NEN, Boston MA), 1-15 Jlg
protein, with or without AOPCP. The reaction was terminated by addition of
200 JlI of 5% w /v ZnS04, mixing, and addition of 200 JlI of 0.3 N Ba(OHh.
Tubes were mixed and centrifuged for 10 min in an Eppendorf tabletop
centrifuge and 0.9 ml of clear supernatant was removed and counted with a
Packard Tri-Carb(I Model 4530 scintilation counter in 5 ml Optifluor(I
scintilation cocktail. 5'-nucleotidase activity was measured as the rate of
formation of 14C-adenosine in the supernatant.
Statisti For statistical evaluation, each experiment consisting of a
tissue segment from a single rat or a separate population of adipocytes pooled
from 3-8 rats was considered to be an independent observation. Means and
standard errors from 4-16 replicate experiments were analysed by ANOV A for
repeated measures (Winer, 1962; Bliss, 1967) followed by pair-wise t-test
(Snedecor and Cochran, 1989) to determine statistical significance using the
computer program StatsView(I (Abacus Concepts, Inc. Berkeley, CA).
Results
The role of cyclic AMP in growth hormone-induced lipolysis
a. Effects GH Dex on cerol roduction
Typical lipolytic effects of GH and dexamethasone are shown in
Figure 3. To obtain these data, duplicate segments of fat tissues from 8 rats
were incubated in the absence or presence of GH (30ng/ml), dexamethasone
(1 Jlg/ml), or both (GH/Dex) for 3 hours. One tissue segment of each pair was
then removed for cyclic AMP assay while the other was transferred to fresh
medium for a final hour of incubation. At the end of the 4th hour the tissues
were prepared for cyclic AMP assay and the medium was assayed for glycerol.
Lipolysis was significantly increased in tissues treated with GH alone (143%;
p.c0.05) or GH/Dex (307%; p.c0.01). The small effect of dexamethasone was
not significant. Note that the combination of GH/Dex produced a
considerably greater increase in lipolysis than the sum of the effects of GH
alone and dexamethasone alone. Growth hormone alone increased glycerol
production from 1.85 to 2.8 Jlmoles/ g/hr while the combination of GH/Dex
increased glycerol production from 1.85 to 5.56 Jlmoles/ g/hr, an effect 4 times
greater than that of GH alone.
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Effects of GH and dexamethasone on lipolysis in fat segments. Tissues
were incubated with and without hormones for 3 hours then transferred to
fresh medium of identical composition for 1 final hour. Medium from
the final hour was assayed for glycerol content. Significant increases in
lipolysis were seen in tissues treated with GH or GHIex. Each bar
represents the mean and s. m. of 16 replicates.
. Effe ts on c AMP c ncen atio
Cyclic AMP was measured in tissues from the same rats 
ilustrated in Figure 3. Tissues were homogenized at the end of 3 or 4 hours
of incubation with GH/Dex to provide an estimate of the cyclic AMP
concentration at the beginnng and end of the interval in which lipolysis was
assessed and when the lipolytic action of GH/Dex is fully developed (Fain 
al. 1965). Despite increased rates of lipolysis seen in tissues incubated with
GH alone, dexamethasone alone or the two hormones together, no
measurable differences in cyclic AM content were detected (Figure 4).
Effect of Rp-CAMPS on lipolysis
Failure to detect an increase in cyclic AMP in tissues treated with
GH/Dex suggests two possibilties: (a) cyclic AMP may not playa role in GH
induced lipolysis or (b) changes in cyclic AMP concentrations that are too
small to detect are sufficient to stimulate lipolysis. Therefore as an
alternative approach to determining if cyclic AMP has a role in GH induced
lipolysis, we examined the effects of a competitive inhibitor of cyclic AMP,
Rp-CAMPS (Rothermel et al. 1983), on the abilty of GH/Dex to increase
lipolysis (Figure 3). Ten segments of epididymal fat from each of 8 normal
rats were incubated for 3 hours in the absence of hormones, or with 
alone, dexamethasone alone or the combination of GH/Dex. At the end of
this preincubation period the tissues were transferred to fresh medium
containing the same hormones and incubated for a final hour. In addition,
some tissues that pre-incubated without hormones for the first three hours
were transferred to medium that contained 0.3 ng/ml isoproterenol and 0.
mg/ml ascorbate. This concentration of isoproterenol was chosen because it
produces a similar increase in lipolysis as GH/Dex. Half the tissues were
exposed to Rp-CAMPS during the last hour of incubation. Rp-CAMPS had
no effect on basal lipolysis, but attenuated GH/Dex- or isoproterenol-induced
lipolysis to a similar extent. Rp-CAMPS decreased the GH/Dex-dependent
production of glycerol by -50% and the isoproterenol-dependent production
of glycerol by 40% (Figure 5). We did not attempt to block lipolysis more
completely with higher concentrations of Rp-CAMPS because its inhibitory
action self-limiting. Rp-CAMPS also inhibits cyclic AMP
phosphodiesterase activity and thus allows cyclic AMP to accumulate and
compete for binding sites on protein kinase A. Thus higher concentrations of
Rp-CAMPS are no more effective than the 30 JlM used (Pereira et al., 1987).
The results of this experiment are consistent with the notion that 
increases lipolysis by a pathway that may be cyclic AMP dependent.
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Effects of GH and dexamethasone on cyclic AMP accumulation in fat
tissues. Tissue segments used in figure 3 were homogenized and
assayed for cyclic AMP. No observable differences were seen
between groups. Each bar represents the mean and s. m. of 16
replicates.
Activation of protein kinase 
The apparent discrepancy between the lack of an increase in cyclic
AMP in GH/Dex treated tissues and the finding that Rp-CAMPS inhibited
lipolysis caused by GH/Dex might be resolved with a more sensitive method
for determining changes in cyclic AMP levels. Al though cyclic AMP
concentrations were unchanged when measured in tissue homogenates (i.e.
in total cell water), it is possible that local concentrations of cyclic AMP may
have increased in the immediate vicinity of protein kinase A, the target of
cyclic AMP action. Therefore measurement of protein kinase A activity
might serve a more sensitive index of cyclic AMP concentration at
physiologically relevant cellular loci.
Fat segments (--100 mg) were incubated in 1 ml KRB for 4 hours at
3TC. In GH/Dex-treated tissue segments, both GH (30 ng/ml) and
dexamethasone (1 Jlg/ml) were present throughout the 4 hours 
incubation. For isoproterenol treatment of tissue segments, two
concentrations of isoproterenol were chosen: a lower concentration (0.
ng/ml) to produce a similar increase in lipolysis as GH/Dex and a higher
concentration (1 Jlg/ml) to produce maximal lipolysis. Isoproterenol was
added only for the last hour of incubation. After incubation, tissue segments
were assayed for protein kinase A activity and the media were assayed for
glycerol.
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Effect of Rp-CAMPS on lipolysis. Rp-CAMPS (30 JlM) was present in
the last hour of incubation. Rp-CAMPS significantly reduced GH/ex
and 0.3 nglml isoproterenol-induced lipolysis in fat tissues. Growth
hormone almost doubled lipolysis (p..0.05) while GH/ex and
isoproterenol increased lipolysis by almost 4-fold (p..O.Ol) Each bar
represents the mean and s. m. of l6 replicates. p-values are for
comparisons between control and Rp-CAMPS treatment for each
conditions.
All hormone treatments significantly increased protein kinase A
activity as determined in the absence of exogenous cyclic AMP (Table 1). In
the presence of a saturating concentration of cyclic AMP, protein kinase A
activity was increased to more than 5 times its basal activity, but was not
further changed by any of the hormone treatments suggesting that GH/Dex
did not affect either the synthesis or degradation of the enzyme. When
expressed as a fraction of the maximum protein kinase A activity, GH/Dex
and the higher concentration of isoproterenol significantly increased the
activity ratios.
Table 1
Protein kinase A activity (cpm/10 Jlg protein/10 min)
ISO (0.1 ng/ml) (1 Ilg/ml) GH Dex
(-) cAMP 2775 :! 800 3097 :! 816 5080 :! 825 3158 :! 793
05) OOl) 05)
(+) cAMP 16392 :! 2548 15595:! 1749 15978 :! 1503 15690 :! 1595
Activity 14.9% :! 1.39 18. %:! 2.11 30.89%:! 3.19 18.60% :! 1.92Ratio n. s. OOOI 
Values represent the mean:! s. m. of 16 replicates. 100 mg tissue segments
were incubated in vitro. GH/Dex was present throughout the 4 hours 
incubation whereas isoproterenol was present only during the last hour. 
values were assessed by ANOV A and are for comparisons with control
tissues.
Glycerol production by these same tissues paralleled the activity of protein
kinase A. When glycerol production was plotted as a function of protein
kinase A activity ratios, values for all three hormone treatments fell on the
same straight line (Figure 6). Linear regression analysis of data for control
GH/Dex and two concentrations of isoproterenol revealed a linear relation
between protein kinase A activity ratio and lipolysis with a correlation
coefficient of 99.5%. The data are consistent with the premise that GH/Dex
and isoproterenol stimulate lipolysis through activation of protein kinase A
and suggest that, like isoproterenol, GH/Dex must act at a site in the lipolytic
pathway that lies proximal to protein kinase A to regulate lipolysis.
Effect of GH/Dex on adenylyl cyclase activity
The findings that Rp-CAMPS successfully attenuated GH/Dex
induced lipolysis and that treatment with GH/Dex increased protein kinase A
activity in tissues strongly suggest a role for cyclic AMP in the lipolytic action
of GH. However, the findings do not address the question of whether
GH/Dex may (1) stimulate cyclic AMP production, (2) inhibit cyclic AMP
breakdown or (3) increase protein kinase A sensitivity to cyclic AMP. In
considering the first possibilty, one would expect GH/Dex either to increase
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Glycerol production as a function of PKA activtiy. Each point
represents the mean value obtained in the same 16 experiments as
described in Table 1.. Glycerol production was significantly (po:O.05)
increased in all three hormone- treated groups.
the rate of cyclic AMP synthesis or to decrease the rate of cyclic AMP
breakdown.
To determine whether treatment with GH/Dex has an effect on
cyclic AMP synthesis, adenylyl cyclase activity was measured in cells that were
incubated for 4 hours in the presence of GH/Dex. Immediately after
incubation, the cells were homogenized and the aqueous phase of the
homogenate was centrifuged to obtain the 16k and lOOk pellets as described in
Methods. Adenylyl cyclase was assayed with or without addition of 1 m 
forskolin to the reaction mixture. Forskolin is a diterpene that directly
stimulates adenylyl cyclase (Seamon et al. 1981) and was used to obtain a
maximal catalytic activity.
Growth hormone and dexamethasone increased adenylyl cyclase
activity from 1.71 pmol/Jlg protein/10 min in 16k pellets of control tissues to
13 pmol/Jlg protein/10 min (p.c0.01). This change corresponds to a
doubling in activity ratio from 11.11% to 24 % (p.c0.01). This increase in
adenylyl cyclase activity in cells treated with GH/Dex cannot be attributed to
an increase in the total amount of adenylyl cyclase since the maximal activity
of the enzyme as determined in the presence of forskolin did not increase
with GH/Dex treatment. More than 85% of the activatable adenylyl cyclase
was recovered in the 16k pellet and this amount was unchanged by GH/Dex.
The approximately 15% of adenylyl cyclase found in the lOOk pellet was not
activated by GH/Dex. The finding that treatment of adipocytes with GH/Dex
increases adenylyl cyclase activity is consistent with the hypothesis that
lipolytic action of GH/Dex may be attributed to an increase in cyclic AMP
production followed by activation of protein kinase A, of hormone-sensitive
lipase, and ultimately lipolysis. This finding, however, raises the question of
how GH/Dex-treatment increases adenylyl cyclase activity in fat cells.
TABLE 2
Adenylyl cyclase activity (pmollJlg protein/10 min)
16k pellet
16k pellet +forskolin
Activity Ratio
GH Dex
n=6
13 :! 0.34
13.27:! 1.
23.98% :! 3.
-values
0047
004
lOOk pellet 0.13 :! 0.
lOOk pellet +forskolin 1.10:! 0.Activit Ratio 11.64% :! 1.07
p-values are for comparisons with control.
0.32 :! 0.
95 :! 0.
10.84 % :! 1.27
Effect of pertussis toxin
Adenylyl cyclase activity is under both stimulatory control mediated
by G and inhibitory control, mediated by Gi. The work by Kather et al. , (1985)
provides strong evidence that adenylyl cyclase in human adipocytes is
maintained at basal levels by tonic inhibition. It is thus apparent that
adenylyl cyclase may be activated either through increased stimulatory input
or through decreased inhibitory input. Growth hormone therefore might
affect adenylyl cyclase activity by increasing or decreasing the relative
amounts or effectiveness of G or Gi' Studies by Goodman et al., (1988)
indicated that GH preferentially decreased Gi in adipocyte ghosts. Such a
decrease might somewhat relieve adenylyl cyclase of inhibition.
evaluating this possibilty it was necessary first to determine if adenylyl
cyclase in rat adipocytes is also under tonic Gi-mediated inhibition under
basal conditions. We therefore incubated adipocytes with 1 Jlg/ml pertussis
toxin to inactivate Gi and transferred the cells to fresh medium every hour
(Figure 7). Glycerol assays were performed on samples of incubation
medium from each hour. After a delay of --2 hours pertussis toxin
dramatically increased glycerol production to an apparently maximal rate 
compared to the effects of high isoproterenol in Figure 4. These data support
the idea that lipolysis is under tonic Gi-mediated inhbition in the basal state
in rat adipocytes as well as in human fat (Kather et ai., 1985). This
observation and the findings of Goodman et al. (1988) support the possibilty
that GH might promote lipolysis in adipocytes by decreasing relative input
from G
Partitioning of proteins
If stimulation of lipolysis by GH is achieved through decreasing Gi
and results in increased adenylyl cyclase activity, then three possible
mechanisms may account for such an action: (1) Gi synthesis may 
decreased, (2) Gi degradation may be increased, or (3) Gi may be removed
from the vicinity of adenylyl cyclase and translocated to another part of the
cell. The slow turnover of G proteins in fat cells (tl/2 24-48 hours) as shown
by Hadcock et al. (1991), makes the first possibilty unlikely and the second
possibility untestable under circumstances that are relevant to our
experimental model. We therefore examined the other possibilty that G
"II
proteins may be selectively translocated from the plasma membrane to
lighter membranous compartments (Haraguchi and Rodbell, 1990).
hypothesized that GH may decrease the accessibilty of adenylyl cyclase to Gi
and thereby increase adenylyl cyclase activity.
To explore this possibility four replicate experiments were
performed. In each experiment, fat cells pooled from 10 rats were incubated
for 4 hours; half with and the other half without GH/Dex. Immediately
following incubation, cells from both groups were homogenized and the
aqueous layer of the homogenate was separated into 16k and lOOk pellets by
centrifugation as described in Methods. Both pellets were resuspended in 
ml .of homogenization buffer. 100 JlI aliquots of each were solubilzed in
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Effect of pertussis toxin on lipolysis in segments of adipose tissue from
normal rats. Pertussis toxin (1 Jlglml) was present in incubation
medium only during the 1st hour of incubation. Tissues were
transferred to fresh medium every hour and samples of medium from
each hour were assayed for glycerol released. Each point represents the
mean and s. m. of 8 replicates.
Laemmli buffer and the proteins separated by electrophoresis in 10%
polyacrylamide gels. Resolved proteins were transferred onto nitrocellulose
membranes and probed by Western blotting with anti-Gia2 and anti- a as
described in Methods and visualized by chemiluminescence. A typical
experiment shows that the G proteins in the 16k pellets are sufficiently
abundant to be observable after 1 min of exposure of the X-ray fim, while the
proteins in the lOOk pellets were visible only after 30 min exposure (Figure 8).
Since each band represents 10% of the G proteins present in either the 16k or
lOOk pellet, we can estimate their relative abundance from the intensity of
the enhanced chemiluminescent reaction. To calibrate this reaction, we
spotted aliquots of serially diluted horseradish peroxidase-conjugated
antibody on nitrocellulose. After soaking for 1 min in ECL(I reagent
(Amersham, Arlington Heights, IL), the membranes were exposed to X-ray
film for 1 min or 30 min. Comparable intensities were obtained after lor 30
min of exposure when the horseradish peroxidase-conjugated antibody
differed by a factor of 4. That is, a 1:1000 dilution of horseradish peroxidase-
conjugated antibody gave as dense a band after 1 min as a 1:4000 gave in 30
mIn. Therefore we estimate that the 16k pellet contains roughly 4 times
more Gia2 than the lOOk band.
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A representative experiment showing the changes in distribution of Gi and Gs in
homogenates of control and GHlex treated cells. Cells were homogenized and
after removal of the fat cake from the homogenates the infranatants were separated
to l6k and lOOk pellets. The pellets were dissolved in Laemmli buffer and
proteins resolved on 10% SDS-PAGE, transferred onto nitrocellulose and probed
with anti- a2 and anti- a. Adipocytes treated with GHlex (G) had more G
in the l6k pellet than control (C) while the lOOk pellet contained more Gia2 in the
control condition than in the GHlex condition. Similar data were obtained in 3
other experiments. The upper panel show the results after 1 minute of the
chemiluminescence reaction and the lower panel shows exposure of the same
nitrocelullose membrane for 30 min to permt visualization of G a in the lOOk
pellet.
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Due to the variabilty in exposure times needed for the 16k and lOOk
pellets, as well as variability in exposure times from experiment to
experiment, intensities of the Gia2 and Gsa bands in aliquots of GH/Dex
treated tissues were normalized to the intensities obtained simultaneously in
controls. That is, for each experiment, the densities of bands representing
treatment with GH/Dex in 16k and lOOk pellets were expressed as a
percentage of the bands representing untreated 16k and lOOk pellets
respectively. Accordingly, treatment with GH/Dex decreased Gia2 in the 16k
pellet by 35% when compared to control. This decrease was associated with a
70% increase in Gia2 in the lOOk pellet (Figure 9).
In an attempt to further refine these observations, particulate matter
in the 16k pellet of control and GH/Dex treated fat cells were separated on
linear sucrose gradients with densities ranging from 5-25%. These gradients
were divided into 1 ml fractions (from lightest to heaviest) and each fraction
was analyzed by quantitative Western blotting. Treatment of adipocytes with
GH/Dex produced a shift of Gia2 from heavier fractions of plasma membrane
to lighter membrane fractions (Figure 10 and 11) but had no effect on the
distribution of Gsa. GH/Dex also had no effect on the partitioning of the
membrane marker enzyme 5' -nucleotidase (Figure 12). In contrast
isoproterenol (lJlg/ml) produced a shift of 5'-nucleotidase towards lighter
fractions, in agreement with the findings of Haraguchi and Rodbell (1990).
To determine whether GH/Dex-induced changes in the distribution
of Gia2 along the density gradient was restricted to the a-subunit or involved
the entire trimeric complex, fractions of plasma membrane were subjected to
ribosylation by pertussis toxin. The 16k pellets were prepared for sucrose
gradients as described above. Each fraction was then incubated for 30 min
with (32P)-NAD and 2 Jlg/ml pertussis toxin. After ADP-ribosylation
fractions were separated on 10% SDS-P AGE followed by quantitative
autoradiography as measured by densitometry. The ribosylation data
confirmed the Western data and showed a GH/Dex-induced shift of Gi from
heavier to lighter membrane fractions. The data further suggest GH/Dex
causes the entire G protein complex to redistribute to a lower density fraction.
However, the design of the experiment does not address the question of
whether the observed shift of Gi distribution to lighter fractions was due to
an overall change in the membrane preparation due to GH-treatment (for
example GH may change the distribution of actin adjacent to plasma
membranes such that membranes from GH-treated cells are lighter) or
whether there is a partitioning of Gi to lighter membrane vesicles. However
GH were to cause plasma membrane to become lighter, we should expect to
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Changes in distrbution of Gi and Gs in homogenates of GH/ex treated cells.
Preparation of saples for Western analysis was performed as descrbed in
Figur 8 and in Method. Intensity of band staing, by imunoblotting with
anti-Gia2 and anti-Gsa , was estiated by densitometr. Each bar represents 4
experients. Due to the varabilty of exposure from experient to experient,
l6k and lOOk bands from GHJx treate samples were normsed with their
control band. Values of cells treated with GH/ex were expressed as a
percentage of values from control cells.
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Effect of GH/Dex on the distribution of Gja2 in the 16k pellet. 16k pellets were
fractioned on a linear sucrose gradient followed by Western analysis of the
resultant fractions. Nitrocellulose membranes containig G proteins were
probed with anti-Gia2 and anti-Gsa as described in Methods. GH/Dex induced s
selective re-distribution of Gia2, but not Gs , from higher density fractions to
lower density fractions. Shown are the results from a typical experiment of
which a total of four replicated experiments were performed.
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see all components of the membrane to shift evenly however only a
selective change in the distribution of Gia2 was observed; the distributions 
, and 5' -nucleotidase as well as adenylyl cyclase (Table 2) were unaffected.
Effect of colchicine on partitioning of proteins and lipolysis
To determine how Gia2 might be partitioned we next explored the
possibilty that the cytoskeleton might be involved. We therefore examined
the effect of disruption of the cytoskeleton with colchicine on the distribution
of Gia2 and Gsa. After the 4th hour of incubation with GH/Dex, the cells were
homogenized. The homogenate was separated into 16k and lOOk pellets and
the pellets were analyzed on Western blots by using anti-Gia2 and anti- a as
described above. Again treatment with GH/Dex decreased Gia2 in the 16k
pellet and increased Gia2 in the lOOk pellet. Colchicine completely abolished
the changes by GH/Dex, that is, there was no reduction in Gia2 in the 16k
pellet nor accumulation in the lOOk pellet (Figure 13).
If redistribution of Gia2 is the causal event in GH stimulated
lipolysis, then colchicine should also prevent GH/Dex induced lipolysis. To
test this idea, we incubated adipocytes with and without GH/Dex for 4 hours
in tl)e absence or presence of 100 JlM colchicine. Samples of medium were
removed at the beginnng and at the end of the 4th hour of incubation for
glycerol assay to determine the rate of glycerol release. Again, fat cells that
were incubated with GH/Dex showed more than a 2-fold increase in lipolysis
Ol). Colchicine completely abolished the increase in glycerol production
(Figure 14; p Ol) while having no effect on the basal rate of lipolysis. To
test whether the decreased glycerol release by colchicine was due to non
specific inhibition, replicate aliquots of colchicine treated or control cells were
treated with 1 Jlg/ml isoproterenol in the 4th hour of incubation. A typical
lipolytic response to isoproterenol, 7-8 -fold increase in lipolysis (p OOl), was
obtained even in the presence of colchicine suggesting that cells were stil
viable and that lipolysis induced by isoproterenol was insensitive to
colchicine. These findings are consistent with the notion that GH/Dex
regulates cyclic AMP and adenylyl cyclase by a different mechanism from that
of the catecholamine.
140
16k
120 (I lOOk n.s.
100
)).
n.s.
)).
GH/ex GH/Dex + Colchicine
ure 
Changes in distribution of G.a in homogenates of GH/ex treated cells
in the absence and presence 6f1. 00 JlM colchicine. Mter 4 hours
incubation in the presence of colchicine, samples were prepared as
described in Figure 8 and Methods. Each bar represents the mean and
m. of the ratio of G a content in GH/ex treated and control cells
for 4 experiments as detefined by densitometry from Western analysis.
p-values are for the differences between experimental values and 100%.
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The effects of colchicine on lipolysis produced by GHlex or
isoproterenol. Adipocytes were incubated for 4 hours in the absence or
presence of 100 JlM colchicine. Glycerol production was calculated as
the difference in glycerol content in incubation medium between the
beginning and the end of the 4th hour of incubation. As before GHlex
increased glycerol production by 2.5 times greater than control while a
high dose of isoproterenol (1 Jlglml) increased glycerol production by
fold. Each bar represents the mean and s. m. of 4 replicates. The p-
value shown is for the comparison between (- )colchicine and
(+ )colchicine in GHlex treated cells.
Discussion
Various lines of evidence have been important in implicating cyclic
AMP as the intracellular mediator of the lipolytic hormones. Fast-acting
lipolytic hormones such as adrenaline increase cyclic AMP concentrations 
adipocytes and stimulate adenylyl cyclase in broken-cell preparations. The
presence of an adrenaline-sensitive adenylyl cyclase system in adipose tissue
homogenates was reported by Sutherland and RaIl (1960) and Klainer et ai.,
(1962). Also, Vaughan (1960) showed that phosphorylase activation, which
might be taken as an indirect measurement of tissue levels of cyclic AMP, and
lipolysis were both increased in fat pads incubated with catecholamine
ACTH, TSH, or glucagon. Vaughan and Steinberg (1963) provided additional
and strong evidence when they reported that the methylxanthine, caffeine, an
inhibitor of cyclic AMP phosphodiesterase, acted synergistically with
adrenaline on lipolysis. Finally, Rizack (1964) reported the activation of an
adrenaline sensitive lipase activity by cyclic AMP in cell-free preparations of
fat pads incubated with ATP, Mg+2, and caffeine. In 1965 , Sutherland et al.
show that the analog dibutyryl cyclic AMP activates lipolysis in fat tissues,
however, this compound may act as a more permeant and stable form of
cyclic AMP and may also inhbit cyclic AMP breakdown. The early studies on
the role of cyclic AM in lipolysis have been comprehensively reviewed by
Robinson et ai., (1971).
Previous studies of changes in cyclic AMP in adipocytes in response
to GH produced conficting or contradictory results. Sengupta et ai., (1981)
found that GH (20 Jlg/ml) increased cyclic AMP levels in perifused fat cells
but had no effect in flask-incubated fat cells. In these experiments, however
measurements of cyclic AMP were made only in the first hour of incubation
with GH, bringing into question the significance of their findings since
lipolysis is normally not increased by GH until considerably later (2-3 hours).
Also, if the growth hormone preparation were contaminated with 0.
ACTH or TSH, these agents would be enough to account for this lipolysis.
Harris and Bennun (1976) also showed that GH was not capable of activating
adenylyl cyclase in normal rat adipocytes but they too studied cells only after
15 min of incubation with GH and theophyllne, well before any lipolytic
effect might be expected (Fain et ai., 1965). Moskowitz and Fain (1970) were
able to show an increase in cyclic AMP concentrations in fat cells after 4 hours
of incubation with GH and dexamethasone but only when theophylline was
also present. Theophylline, an inhbitor of cyclic AMP phosphodiesterase, is
now known to also be an adenosine Al receptor antagonist (Ukena et ai., 1993;
Daly, 1982). The adenosine Al receptor is coupled to Gi. By blocking the Al
receptor it is possible that theophyllne might also block or decrease the
inhibitory input to adenylyl cyclase. Thus, theophyllne may elevate levels of
cyclic AMP by relieving inhibition on adenylyl cyclase as well as by protecting
cyclic AMP from enzymatic degradation. Therefore, experiments performed
with GH in the presence of theophyllne raise the question as to which agent,
GH or theophyllne or both, might produce substances that promote adenylyl
cyclase activation thus increasing cyclic AMP.
The present experiments differed from earlier studies in that we
restricted our measurements of response to GH/Dex to effects seen after 3
hours of incubation. We used no additional agents such as theophyllne 
preserve or amplify putative effects on cyclic AMP accumulation because
those agents were not needed to preserve or amplify effects on lipolysis. 
found no differences in cyclic AMP concentrations between control and
tissues treated with GH/Dex, and can conclude one of two possibilties: (1)
cyclic AMP is not involved in GH-induced lipolysis or (2) cyclic AMP is
involved but does not require a measurable change in its bulk intracellular
levels.
In considering the first possibilty, a recent survey of the literature
has shown no other lipolytic pathways than the classical cyclic AMP-protein
kinase A-mediated pathway. However, recent work by Gorin et ai., (1990)
have demonstrated a role of protein kinase C in isoproterenol- and GH-
induced lipolysis but the authors concluded that the effects of protein kinase
C are likely proximal to cyclic AMP and are of a permissive nature rather than
a direct stimulatory effect on lipolysis.
There are, however, some precedents for increased lipolysis without
increased cyclic AMP. Despite the vast literature on cyclic AM and lipolysis,
there appears to be no firm experimental basis for evaluating the quantitative
relationship between these two parameters. For example, Manganiello et ai.,
(1971), Schimmel (1974), and Fain et ai., (1979) have shown that exposure of
adipocytes to lipolytic hormones results in a linear increase in the rate of
lipolysis that, paradoxically, coincide with a transient rise and fall in cellular
cyclic AMP concentrations. Manganiello et ai. (1971) found that the peak
level of cyclic AMP was attained between 4 and 7 min after addition of
adrenaline or ACTH while the rate of lipolysis remained unchanged even as
the cyclic AMP levels rise and fall. They also found that the steady state level
of cyclic AMP needed to produce a maximum lipolytic rate was quite low
compared to the transient peak level but did find a close correlation between
adenylyl cyclase activity and lipolysis. They suggested that cellular cyclic AMP
may have a very short half-life (high turnover rate) (Manganiello et al. , 1971).
Schimmel also observed a rise and fall in levels of cyclic AMP in adipose
tissue within 15 min of addition of adrenaline while the rate of lipolysis
continued to increase even 1 hour after addition of adrenaline. Similarly,
Fain et ai., (1979) observed a sustained maximal rate of lipolysis 60 min after
addition of noradrenaline even though cyclic AMP levels had already
dropped to near basal levels. Schimmel (1974) and Fain et aZ. (1979) suggested
that the observed discrepancy between lipolytic rate and cyclic AMP levels
may be due to different pools of cyclic AMP and suggested that the pool of
cyclic AMP measured in their studies was not closely coupled to the lipolytic
machinery and therefore the lipolytic rate may be modified with no dramatic
change in the measured cyclic AMP levels.
Our data reflect some very interesting discrepancies which cannot be
explained by assuming that the cytosol is a uniform "soup , a condition
reproduced by experiments using cell extracts in cell free solutions.
assume that rat adipocytes have type II protein kinase A (Beebe and Corbon
1984), with affinity for 'cyclic AMP at Ka =78 nM (Ekanger et aI., 1985). Our
assay shows both resting and hormone activated cyclic AMP levels to be
roughly 0. 0.4 JlM and if so, we would expect all cyclic AMP binding sites on
protein . kinase A to be occupied and the kinase completely activated.
However, because phosphodiesterase has a greater affinity (Krn::10 nM; Barber
and Sutherland, 1992) for cyclic AMP than Type II protein kinase A (Ka=78
nM; Ekanger et ai., 1985), and the rate of cyclic AMP synthesis (1.56
nmol/min/Jlg protein), as measured in the presence of forskolin, is much
lower than the rate of degradation by Type IV phosphodiesterase (8.
Jlmol!min/Jlg protein; Manganiello et al. 1992), one would expect very little
cyclic AMP accumulation, if any, in the cytosol. This problem may be
resolved if there exists a cellular architecture which places protein kinase A
and adenylyl cyclase in close proximity to each other thus allowing the newly
synthesized cyclic AMP to activate protein kinase A before degradation by
phosphodiesterase.
Both Manganiello et ai., (1971) and Schimmel (1984, 1974) suggested
that the discrepancy between cyclic AMP levels and lipolytic rates may be due
to multple pools of cyclic AMP in different functional compartments of the
cytosol. Other evidence in support of compartmentalization of cyclic AMP
signalling components within the adipocyte comes from the work of
Honeyman et al. (1979) who showed that adrenaline and serotonin both
increase cellular levels of cyclic AMP and accelerated glycogenolysis but only
adrenaline increased lipolysis. The interpretation of these findings by
Honeyman et al. (1979) was that adipocyte cyclic AM must be sequestered in
different "pools . Catecholamine may increase cyclic AMP accumulation in
one pool, that is co-localized with protein kinase A, phosphorylase and
hormone-sensitive lipase, while serotonin may promote cyclic AMP
accumulation in another pool that is co-localized with protein kinase A and
phosphorylase only. As well, Hollenga et al. (1991) demonstrated that BRL
37344, a 3-adrenergic receptor agonist (Hollenga and Zaagsma, 1989) and
isoproterenol produced the same degree of maximal lipolysis in adipocytes.
However, the cyclic AMP levels required to produce maximal lipolysis by BRL'
37344 was only 20% of the levels needed with isoproterenol. BRL 37344
increased lipolysis without an apparent increase in cyclic AM or with only a
very small increase in cyclic AMP may be explained by intracellular
compartmentalization in which significant increases in cyclic AMP might be
confined to small areas in the vicinity of protein kinase A as suggested by
Hollenga et al. (1991) and Pohl (1981). More recently, Ashida and Sakuma
(1992) provided evidence for compartments of cyclic AMP in rat platelets by
using specific phosphodiesterase inhibitors. In their studies, one pool of cyclic
AMP was responsible for platelet aggregation and sensitive to degradation by
a cyclic AMP-specific phosphodiesterase, while another pool of cyclic AMP
was responsible for the platelet release reaction and sensitive to degradation
by a cyclic GMP-specific phosphodiesterase (Ashida and Sakuma, 1992). These
studies (Manganiello et al., 1971; Schimmel, 1974, 1984; Honeyman et ai., 1979;
Hollenga et al. 1991; Ashida and Sakuma, 1992) and our findings further
support the notion of functionally separate pools of cyclic AMP in intact cells.
Because it is possible for a small change in cyclic AMP to 
undetected and yet to be sufficient to promote lipolysis, it was necessary to
establish whether cyclic AMP plays a role in GH/Dex induced lipolysis by 
approach other than direct measurement. To this end, the cyclic AMP
antagonist Rp-CAMPS (Rothermel et al. 1983), was used. Rp-CAMPS, the Rp
isomer of adenosine 3' phosphorothioate, competes with cyclic AMP for
binding sites on the regulatory subunits of protein kinase A, but unlike cyclic
AMP, Rp-CAMPS cannot induce the conformational change in tl)e regulatory
subunts necessary for the release of the catalytic subunits (de Wit et al., 1988;
Parker-Botelho et al. 1988), Although Rp-CAMPS decreased GH/Dex induced
lipolysis, it did not completely abolish the lipolytic effect of GH/Dex. Others
have also reported the partial effectiveness of Rp-CAMPS at blocking cyclic
AMP-dependent processes. Adashi et al., (1990) reported that Rp-CAMPS, at a
concentration of 1 mM, only partially blocked FSH-stimulated progesterone
accumulation in granulosa cells. This may be attributed to the abilty of Rp-
CAMPS to compete with cyclic AMP for binding to phosphodiesterase and
thus inhibit cyclic AMP degradation leading eventually to a buildup of
endogenous cyclic AMP which then overcomes the inhibition produced by
Rp-CAMPS. Pereira et al., (1987) had noted that at concentrations greater than
30 JlM Rp-CAMPS was not an effective cyclic AMP inhibitor. Therefore we
chose a concentration (30 JlM) of Rp-CAMPS that would effectively inhbit
cyclic AMP while minimally inhibiting phosphodiesterase. Inhibition of
GH/Dex induced lipolysis by Rp-CAMPS is strong and suggestive, but not
conclusive evidence that cyclic AMP mediates the acceleration of lipolysis
induced by GH.
In an attempt to further explore the role of cyclic AMP in GH
induced lipolysis a more direct and sensitive technque was employed: the
protein kinase A assay (Corbin, 1983). Whereas our assay of cyclic AMP
measured the total cyclic AMP levels within the tissue segment, assay of
protein kinase A activity would reflect the functional levels of cyclic AMP; i.e.
those participating in protein kinase A activation. The protein kinase A
holoenzyme consist of two catalytic and two regulatory subunits (Taylor 
aI., 1990). Each regulatory subunit has two cyclic AMP binding sites.
Occupation of the first cyclic AMP binding site on each regulatory subunit
increases the affinity of the other. Because of this strong positive
cooperativity of cyclic AMP binding, small changes in cyclic AMP can produce
large changes in bound cyclic AMP and protein kinase A activation (Rannels
and Corbin, 1981). Thus changes in cyclic AMP levels which might be too
small to detect in radioimmunoassays, either in the whole cell or within the
proximity of protein kinase A, might nevertheless be large enough to activate
protein kinase A.
Following the work of Honnor et ai., (1985) we measured
endogenously activated protein kinase A as a function of maximal available
protein kinase A as determined in the presence of saturating amounts of
cyclic AMP. Consistent with the notion that GH/Dex induces lipolysis
through a cyclic AMP-dependent pathway, a greater fraction of protein kinase
A was activated in fat tissues in which lipolysis was accelerated by GH/Dex.
Activation of protein kinase A might occur in several ways: (1) it may result
from elevation of cyclic AMP levels within the adipocyte, (2) the affinity of
protein kinase A for cyclic AMP may be increased so that there may be greater
fractional activation in the presence of constant levels of cyclic AMP, or (3)
sites of cyclic AMP production may be brought into closer proximity to
protein kinase A so that activation of protein kinase A occurs more efficiently
with only small changes in local levels of cyclic AMP.
Activation of protein kinase A by increased concentrations of cyclic
AMP is well established in the literature (Taylor et al. 1990). However, there
is also evidence to support the hypothesis that sensitivity of protein kinase A
to cyclic AMP may not be constant. Protein kinase A exists as 2 isoforms: type
I and tye II (for review see Taylor et al. 1990) which have identical catalytic
subunits but different regulatory subunits (Hanks et al. 1988; Taylor et al.,
1990). The two isoforms of protein kinase A are functionally distinguishable
on the basis of their interaction with MgATP (Taylor et al. 1990). Only the
type I holoenzyme binds MgATP with a high affinity and exists in the cell as a
ternary complex containing a regulatory subunit, a catalytic subunit, and
MgATP. In addition to increasing the amount of cyclic cAMP necessary to
activate the holoenzyme, MgA TP also promotes the reassociation of the
tegulatory and catalytic subunits of the type I holoenzyme thus hastening its
inactivation. The type II holoenzyme may exist in a phosphorylated and a
dephosphorylated state. When phosphorylated the type II isozyme has a
lower affinity for the catalytic subunit and thus dissociates at a lower
concentration of cyclic AMP than when dephosphorylated (Rosen and
Erlichman, 1975; Hoffmann et al., 1975; Rangel-Aldao and Rosen, 1977). In
epididymal adipocytes, the predominant isoform of protein kinase A is type 
which comprises 90% of the total protein kinase A (Corbin, 1983). Therefore
it is possible that the lipolytic actions of GH may be achieved through
phosphorylation of protein kinase A resulting in a greater sensitivity for
cyclic AMP for activation.
Although the idea that GH might sensitize protein kinase A to cyclic
AMP through phosphorylation is attractive, this does not appear to be the
case. The type II isoform of protein kinase A is present primarily in its
phosphorylated form (Taylor et al., 1990) and thus already sensitized to cyclic
AMP in the absence of GH. Also, it has been shown that the lipolytic
response to dibutyryl cyclic AMP, a membrane permeable analog of cyclic
AMP, is not enhanced by GH pretreatment suggesting the sensitivity of
protein kinase A to dibutyryl cyclic AMP was not enhanced with 
pretreatment (Fain, 1968; Goodman, unpublished data).
If GH directs cyclic AMP to a functional compartment in which
protein kinase A is abundant and has access to hormone-sensitive lipase, one
might expect that GH would direct dibutyryl cyclic AMP or 8-bromo-cyclic
AMP towards a compartment with protein kinase A and thus enhance their
lipolytic actions. However, the work by Fain (1968) and Goodman
(unpublished data) indicates that GH does not increase lipolysis induced by
the cyclic AMP analogs. These studies are inconclusive, however, since
exogenous dibutyryl cyclic AMP and 8-bromo-cyclic AMP may not distribute
in the same way as endogenously produced cyclic AM.
Honnor et al., (1985) also examined a variety of lipolytic hormones
including isoproterenol, glucagon, and ACTH, known to stimulate lipolysis
through the cyclic AMP-dependent pathway (Birnbaumer et al. 1985) to see
what effect these agents had on protein kinase A activity. They found that
regardless of the lipolytic agent tested, maximal lipolysis was achieved when
40% protein kinase A was activated. There was a direct correlation between
the rate of glycerol production and the protein kinase A activity ratio up until
maximal lipolysis was reached. Upon stimulation with even higher
concentrations of agonist, the activity ratio of protein kinase A continued 
increase suggesting that hormone-sensitive lipase, rather than protein kinase
A or adenylyl cyclase had become rate-limitng. (Honnor et al. 1985). This
finding further indicated .that the relationship between protein kinase A and
hormone-sensitive lipase is independent of the agent used. Although we
only examined the lipolytic effects of GH/Dex and of two concentrations of
isoproterenol we found that the same relationship between protein kinase A
activity and lipolysis held for GH/Dex as for isoproterenol suggesting that
GH/Dex must act prior to activation of protein kinase A. If GH does indeed
activate protein kinase A by elevating cyclic AMP levels within the adipocyte
it must also increase adenylyl cyclase activity.
Growth hormone could increase adenylyl cyclase activity by several
possible mechanisms: (1) stimulation through the action of G on cyclase or
(2) removal of inhibition mediated by G (Gilman, 1987) or (3) stimulation by
a G protein independent mechanism. Interaction with G activates adenylyl
cyclase and thus increases cyclic AMP formation. Alternatively, by decreasing
the inhibitory influence of Gi on adenylyl cyclase, either through inactivation
or decreased abundance, a state of partial stimulation may be achieved. Our
finding that pertussis toxin increased lipolysis, after 2 hours, provides
evidence that the activity of adenylyl cyclase may be increased by inactivation
of Gi, or loss of receptor coupling and is in agreement with the findings in
other investigators (Moreno et ai., 1983; Olansky et ai., 1983, Kather et al.
1985) who also reported lipolytic effects of crude preparations of pertussis
toxin. Finally, to our knowledge, there is no other mechanism other than G
protein interaction which may regulate adenylyl cyclase.
Goodman et ai., (1988) reported that hypophysectomy increased Gi in
the plasma membranes of adipocyte ghosts and that treatment of rats with GH
4 hours before sacrifice decreased the apparent amount of G i in adipocyte
membranes. They proposed that a diminished level of Gi in the plasma
membrane of adipocytes may result in partial stimulation of adenylyl cyclase
and hence increased lipolysis. Their report of diminished Gi in the plasma
membrane by GH is supported by our findings and the recent report of Doris
et al. (1994) who found that Gia2 increased whenever GH was removed from
circulation for 2 days. Doris et ai., (1994) also showed that this action of GH
was specific for Gia2, the form of inhibitory G protein which various
investigations have suggested is responsible for inhibition of adenylyl cyclase
(Simonds et al. 1989; McKenzie and Miligan, 1990) while leaving Gsa levels
unchanged. Moxham et al., (1993) also showed that Gia2 mediates the
inhibition of adenylyl cyclase when they showed that blocking expression of
Gia2 with antisense RNA blunted the inhbitory response to PIA and resulted
. in a 3. fold increase in basal cyclic AMP accumulation. The data of Moxham
et al. (1993) suggest that as Gia2 decreases, cyclic AMP levels increase,
presumably due to attenuated inhibition of adenylyl cyclase.
Several mechanisms might account for the decrease in Gia2 in the
plasma membrane: (1) GH might decrease the rate of synthesis of Gia2, (2) GH
mipht accelerate the rate of Gia2 degradation, or (3) GH might cause a
dissociation of Gia2 from adenylyl cyclase. In order for the first possibilty to
account for the lipolytic action of GH, a decrease in the synthesis of Gia2
would have to produce a significant decrease in Gia2 within 2-3 hours. The
half-life of G proteins has been reported to range from 72 hours in cardiocytes
(Silbert et al. 1990) to 24 hours in hamster smooth muscle (Hadcock et ai.,
1991) suggesting that even if synthesis was completely shut down, more than
95% of Gia2 would stil be present in the membrane 3 hours after addition of
GH/Dex.
With regard to the alternative mechanism, enhanced Gia2
degradation, Mitchell et al. (1993) reported that the muscarinic M1 receptor
agonist, carbachol, accelerated the degradation rate of G a/Glla in Chinese
hamster ovary cells from a tl/2 of 18 hours to 2.9 hours. They also reported
that this enhanced rate of degradation was specific for G a/Glla since Gs
and Gia2 were unaffected. Accelerated degradation occurred only during the
first 8 hours even when exposure to carbachol was maintained for 60 hours
(Mitchell et al. 1993). Although it is possible that the decrease in Gia2 in the
plasma membrane of adipocytes caused by GH/Dex treatment may be due to
enhanced Gia2 degradation, the slow turnover of Gi precludes metabolic
labelling in our experimental model and hence it was not possible to study
effects of GH on the rate of loss of label from immunoprecipitation of Gia2.
Other results make this unlikely, since the decrease of Gia2 in the 16k pellet
was accompanied by an increase in the lOOk pellet suggesting translocation.
Stimulation of rat adipocytes with isoproterenol has been reported to
induce translocation of Gsa from the dense plasma membrane fraction to
lighter membrane fractions (Haraguchi and Rodbell, 1990). Our findings with
GH/Dex are consistent with the notion that Gia2 may be translocated from
plasma membrane to lighter membrane fractions, but, our findings differ
from those of Haraguchi and Rodbell in that translocation of Gia2 from
plasma membranes to lighter membrane fractions was selective. Haraguchi
and Rodbell (1990) reported that stimulation of adipocytes with isoproterenol
resulted in the translocation of Gia , Gsa, adenylyl cyclase, and 5' -nucleotidase.
In our hands, stimulation with GH/Dex resulted in partitioning of only Gia2
leaving the distribution of Gsa, adenylyl cyclase, and 5' -nucleotidase
unchanged. Haraguchi and Rodbell (1990) attributed the redistribution of
membrane proteins to pinocytosis. The selective redistribution of Gia2 seen
in our studies may also be explained by a pinocytic process in which vesicles
selectively enriched in heterotrimeric Gia2 are removed from the plasma
membrane in much the same manner as vesicles containing the insulin
100
sensitive glucose transporters are removed from the plasma membrane after
insulin dissociates from its receptor (Karnieli et al. 1981). More work wil be
needed to address the question of whether selective redistribution of Gia2
involves pinocytic vesicles. The data further suggest GH/Dex causes the
entire G protein complex and not just the a-subunit to redistribute to a lower
density fraction. However, the design of the experiment doesn t allow us to
determine if the change in distribution of G proteins was due to: (1) an
overall decrease in adipocyte membrane densities or (2) a partitioning of G
proteins to lighter membranes. To address the first possibilty, it is possible
that GH/Dex treatment could result in plasma membranes having densities
lighter than that of untreated cells resulting an apparent redistribution of G
proteins to lighter fractions of a density gradient. However, if this were the
case, then all components of the membrane should be shifted in the density
gradient to an equal extent. This is not the case. We demonstrate that after
treatment with GH/Dex, only the Gia2 is shifted to a lighter fraction of the
density gradient whereas Gsa was unaffected (Figure 9, 10 and 11). Even
adenylyl cyclase, identified by its activity in the presence of forskolin, did not
partition from 16k to lOOk pellet as did Gia2 (Table 2). This selective
redistribution of Gia2 argues against the possibilty that hormone treatment
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results in a non-specific partitioning of membrane components. Since this
partitioning occurs in plasma membranes, the result is a change in the
membrane composition thus Gia2 and Gsa must be physically separated.
The next question is if Gia2 is redistributed to lighter membrane
components by treatment with GH/Dex, does this redistribution represent
movement of individual molecules (Le.: in soluble form) or molecules
associated with membranes (for example pinocytosis)? If it is, indeed, due to
dissociation of Gi proteins from the plasma membrane to intracellular
vesicles, then this would mean that Gi is soluble for a period of time before
anchoring itself to another lipid bilayer. Unless the time interval in which Gi
is soluble is very short, we should lose some of the G in the supernatant
above the lOOk pellet. Upon examination of the data in Figure 9, we see that a
35% decrease in the amount of Gia2 in the 16k pellet corresponds with a 70%
increase in the lOOk pellet. Since the 16k pellet represents roughly 4 times
more Gia2 than the lOOk pellet, the amount of Gia2 recovered in the lOOk
pellet after GH/Dex-treatment represents only half of the material lost from
the 16k pellet. This very crude estimation is consistent with the notion that a
portion of the Gia2 is lost to the soluble portion of the cell extract and may
support the contention that redistribution of GiCX2 to lighter membrane
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components may be due to Gia2 partitioning from plasma membrane to
microsomal" membranes. One may speculate upon a mechanism whereby
the G proteins lose their fatty acid anchor, become unattached from the
plasma membrane, and now that it is soluble within the cytoplasm, re-
distributes to intracellular membrane vesicles and anchors themselves
through re-acylation. However, from our knowledge of G protein structure
and its post-translational modifications, it seems inconceivable for such a
mechanism to be occurring yet partitioning may account for the apparent
discrepancy between the amount of G protein lost in the 16k pellet and the
amount gained in the lOOk pellet. However, since we did not measure the
levels of G proteins in the supernatant of the lOOk pellet, we cannot conclude
that G proteins actually become soluble and then re-anchor themselves to
other membranous particles.
The alternate possibilty is that Gia2 is selectively removed from the
vicinity of G and adenylyl cyclase. Such a separation could upset the balance
of stimulation and inhibition to favor stimulation of adenylyl cyclase. A
mechanism for such removal of Gia2 from plasma membrane may be a
special type of pinocytosis such that predominantly Gia2 is removed from the
plasma membrane rather than G or adenylyl cyclase. Precedence for selective
transloca ion comes from the example of the glucose transporter (Karniell 
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aI., 1981). Upon insulin stimulation, glucose transporters are translocated
from cytosol to plasma membrane presumably through the fusion of
I ;
intracellular vesicles with plasma membrane. When insulin is removed, the
glucose transporters are removed from the plasma membrane by some sort of
pinocytosis which selectively removes the glucose transporters away from the
plasma membrane. The exact mechanism for this selective removal is
unclear.
Recently, work by Anderson (1993a, 1993b) described a process in
which cell membranes form flask-shaped invaginations called caveolae.
Caveolae have the abilty to concentrate small molecules and ions. The
ability of caveolae to concentrate molecules before internalization may
provide a mechanism for selective partitioning of Gia2, although such a
mechanism is purely speculative. We may speculate that GH/Dex treatment
induces the formation of caveolae which allows for the selective
concentration of Gia2 within these caveolae. Since these flask-like structures
can pinch off the plasma membrane to become intracellular vesicles, they
may fractionate with the lOOk pellet and result in the separation of Gia2 from
the plasma membrane. Alternatively, caveolae containing G a2 may not
pinch off the plasma membrane but upon homogenization of the cells, the
actual process of homogenizing cells may disrupte the plasma membrane in
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such a way allowing the formation of small vesicles from caveolae which
may partition with lOOk pellet resulting in an apparent partitioning of Gia2 
lighter membrane vesicles.
Interestingly, the molecular composition of caveolae indicates that
they have the capacity to store and process messengers such as cyclic AMP
calcium, or adenosine and to use non-receptor tyrosine kinases to initiate
crucial phosphorylation cascades (Anderson, 1993a). Therefore, in certain
cells, caveolae may be important in signal transduction.
In 1956, Sir Rudolph Peters hypothesized that hormones act through
the reorientation of the cytoskeletal system. The cytoskeleton, which consists
of microtubules, microfilaments, and intermediate fiaments, is known to
have an important role in regulating cell growth and differentiated functions.
In spite of considerable progress that has been made in understanding
hormone-mediated signal transd ction pathways, relatively little is known
regarding the interaction of cytoskeletal components with these pathways.
Among the cytoskeletal components, microtubules are of particular interest
because they have been implicated in regulation of hormonal responses (for
review see Zor, 1983; Yan and Rasenick, 1990). For example, it has been
shown that disruption of microtubules with colchicine or vinblastine may
increase cyclic AMP formation in several different cell systems (Zor, 1983). In
105
S49 lymphoma cells, colchicine and vinblastine enhanced -adrenergic-
stimulated cyclic AMP accumulation (Insel and Kennedy, 1978; Kennedy and
Insel, 1979). This enhancement seems to be regulated at points proximal to
cyclic AMP production, possibly at the level of G proteins (Yan and Rasenick,
1990). Recent reports have shown specific associations between tubulin and G
proteins (Rasenick et al. 1990;, Wang and Rasenick, 1991). Our data support
the notion that an intact cytoskeleton is necessary for both the redistribution
of Gia2 and lipolytic effect of GH since colchicine blocked both the
redistribution of Gia2 and lipolysis induced by GH. As suggested by
Haraguchi and Rodbell, (1990), G protein translocation may occur by
pinocytosis and the pinocytic process may require an intact cytoskeleton. It is
possible that GH causes the selective removal of Gi from plasma membranes
by pinocytosis and this removal also requires an intact cytoskeleton. This
could conceivably follow from GH-induced structural changes in the
cytoskeleton resulting in invaginations of regions of plasma membranes rich
in Gi leading to vesicles which may translocate to the cytosol.
Another way in which Gia2 may be translocated away from the
plasma membrane is through the "treadmiling" action of microtubules.
Microtubules are simple, linear cylindrical assemblies of tubulin protein
subunits with polarity, a plus end and a minus end. Subunits of tubulin are
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added at the plus end and lost from the minus end yet the microtubule
remains the same length (Hotani and Miyamoto, 1990). The plus end of the
microtubule is located close to the plasma membrane while the minus end is
situated near the nucleus (Hotani and Miyamoto, 1990). The treadmiling
action results in movement of tubulin molecules from the periphery of the
cell towards the nucleus (Hotani and Miyamoto, 1990). Since G proteins have
been found to be associated with microtubules (Rasenick et ai., 1990), it is
possible that a treadmilling action of microtubules is responsible for
redistribution of G proteins and could result in transporting them from
plasma membrane to the interior of the cell. Our findings that GH-treatment
results in redistribution of Gia2 from 16k pellet to lOOk pellet, as well as
redistribution to lighter fractions of the 16k pellet, suggest that Gia2 does not
dissociate from membranes to become a soluble protein. However, we did
not assay the supernatant above the lOOk pellet, for G proteins. The amount
of Gia2 gained in the lOOk pellet may not completely account for the Gia2 lost
from the 16k pellet. Our estimates are crude and it appears that a significant
part of Gia2 lost from dense membranes appears in lighter fractions. Clearly,
further studies wil be needed to uncover the mechanism for redistribution of
Gia2.
f ,
107
Throughou t the studies presented in this disserta tion
dexamethasone has been added along with GH. Some comment about its role
in the lipolytic action of GH is warranted. Although glucocorticoids were
added with GH to amplify the lipolytic effect, there is evidence to indicate that
they do not directly stimulate lipolysis. Fain et al., (1965) demonstrated that
glucocorticoids did not stimulate lipolysis but did enhance lipolysis induced
by GH. Goodman (1968) showed that in the presence of theophyllne, GH but
not dexamethasone increased lipolysis. In addition to enhancing the lipolytic
action of GH, glucocorticoids have also been shown to enhance the lipolytic
action of catecholamine (Allen and Beck, 1972; Goodman, 1970). Goodman
(1970) found that glucocorticoids potentiated the acceleration of lipolysis by
catecholamine but this potentiation was delayed and was abolished by
inhibitors of RNA synthesis.
Since lipolysis is thought to be cyclic AMP-dependent, it is possible
that glucocorticoids act at some point along the cyclic AMP-dependent
pathway. Evidence, as reviewed by Granner (1979) and Fain (1979), suggests
that potentiation of lipolysis by glucocorticoids is not mediated through
changes in cyclic AMP accumulation. No accumulation of cyclic AMP was
found in rat adipocytes after several hours of incubation with glucocorticoids,
however we now know that very small changes in cyclic AMP may be
sufficient to accelerate lipolysis. (Moskowitz and Fain, 1970; Fain et al., 1971;
.. '
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Fain and Saperstein, 1970). Under conditions in which glucocorticoids were
absent (eg. after adrenalectomy), fat cells or fat pads displayed normal
increases in cyclic AMP in response to hormones although the increase in
lipolysis in response to catecholamine was blunted (Exton et al. (1972; Allen
and Beck, 1972; Werner and Low, 1974) suggesting that glucocorticoids had no
direct effect on cyclic AMP production or degradation. Glucocorticoids did
potentiate cyclic AMP accumulation in adipocytes treated with GH (Fain and
Saperstein, 1970) further supporting the notion that it is GH and not
glucocorticoids that is responsible for the increase in cyclic AMP levels.
possible mechanism for enhancement of lipolysis by
glucocorticoids could involve an increase in protein kinase A activity.
Lamberts et ai. (1975) described such an effect in fat cells where prior
incubation for 4 hours with dexamethasone resulted in a 28% increase in
phosphorylation of histone by protein kinase A assayed in the presence 
cyclic AMP. Dexamethasone did not increase basal protein kinase A activity
(Lamberts et al. 1975). These investigators also reported that 2 weeks of
elevated cortisol levels, in vivo, resulted in enhanced lipolysis in response to
dibutyryl cyclic AMP and suggested an increase in protein kinase A as the
reason for the enhancement (Lamberts et al. 1975). However, these results
indicate chronic effects of glucocorticoids and were in contrast to those of Fain
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(1968) and Goodman et al. (1988) who reported no potentiation of lipolysis by
dibutyryl cyclic AMP in cells pretreated with dexamethasone for 4 hours.
More recent evidence suggests that glucocorticoids can increase
adenylyl cyclase activity (Chang and Bourne, 1987; de Mazancourt et ai., 1989;
McLelland et al., 1983), decrease phosphodiesterase activity (Schonhofer
al., 1972; Elks et al. 1983) or increase G (Chang and Bourne, 1987) but, again
these appear to be chronic effects of glucocorticoids which require several days
of treatment and are unlikely to contribute directly to lipolysis in our
experiments.
Glucocorticoids have also been shown to inhibit the release of
prostaglandins, which have an inhibitory effect on adenylyl cyclase (Lewis
and Piper, 1975). It is possible that the slight increase in lipolysis as well as the
potentiating effects of glucocorticoids on lipolysis may be mediated by
blocking the tonic release of prostaglandin.
Thus evidence in the literature does not support an immediate
action (at least within 4 hours) of glucocorticoids on adenylyl cyclase or 
any other component of the cyclic AMP-mediated pathway and is reasonable
to suspect that the lipolytic actions of GH/Dex is mediated by the direct effects
of GH rather than dexamethasone.
In summary, the findings presented in this study support the
hypothesis that stimulation of lipolysis by GH occurs through a cyclic AMP-
...
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mediated pathway. We also present evidence that cyclic AMP levels are
elevated through activation or "de-inhibition" of adenylyl cyclase. Unlike
catecholamine which activate adenylyl cyclase through the agency of
stimulatory G proteins, our findings suggest GH/Dex activates adenylyl
cyclase through relief of inhibition by selectively removing inhibitory G
proteins from the vicinity of adenylyl cyclase. We further present evidence
that the selective removal of Gia2 is achieved through a mechanism that
requires an intact cytoskeleton. Stimulation of lipolysis by GH/Dex but not by
isoproterenol was inhibited by colchicine also suggesting an intact
cytoskeleton is required for GH/Dex to stimulate lipolysis.
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Future Directions
In addition to providing some insight into the mechanism of action
of GH to stimulate lipolysis, these findings also prompt new questions which
wil be pursued in future studies. For example, if GH/Dex does indeed bring
about a change in the structure of the cytoskeleton, how may it do so? As
well, we have not yet demonstrated with what time course this particular
action of GH/Dex takes place. Does redistribution occur immediately upon
GH/Dex exposure to adipocytes or do cytoskeletal changes occur after 2-
hours, the time increased lipolysis is seen? Are specific proteins induced by
GH required for the redistribution phenomenon? Recently Meyer et al.
(1994) reported a signallng pathway between the GH receptor and the
nucleus, consistent with the findings of Fain (1967) in which stimulation of
lipolysis by GH required RNA and protein synthesis. It is possible that the
newly synthesized proteins may be involved in redistribution.
Also there is the question of the role of glucocorticoids in
stimulation of lipolysis by GH. We did not test the possibilty that
redistribution might be the result of GH alone or dexamethasone alone. We
therefore wil need to look for redistribution in adipocytes incubated with GH
or dexamethasone alone. If glucocorticoids are responsible for the selective
Ie.
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redistribution of Gi then redistribution induced by glucocorticoids may
explain some of its permissive effects. Fain (1967) showed that regardless of
the time in which glucorticoids are added with GH, there is always a 1.5-
hour delay before the enhancement of lipolysis induced by GH begins. It is
possible that the glucocorticoid receptor, which can bind to DNA may
somehow facilitate the signallng between GH receptor and nuclear DNA to
promote lipolysis.
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